BE2013C054I2 - - Google Patents
Download PDFInfo
- Publication number
- BE2013C054I2 BE2013C054I2 BE2013C054C BE2013C054C BE2013C054I2 BE 2013C054 I2 BE2013C054 I2 BE 2013C054I2 BE 2013C054 C BE2013C054 C BE 2013C054C BE 2013C054 C BE2013C054 C BE 2013C054C BE 2013C054 I2 BE2013C054 I2 BE 2013C054I2
- Authority
- BE
- Belgium
- Prior art keywords
- antipsychotic
- composition
- mammal
- present
- inhalation
- Prior art date
Links
- 230000000561 anti-psychotic effect Effects 0.000 abstract 6
- 239000000203 mixture Substances 0.000 abstract 5
- 241000124008 Mammalia Species 0.000 abstract 4
- 239000000443 aerosol Substances 0.000 abstract 4
- 239000000164 antipsychotic agent Substances 0.000 abstract 2
- 229940005529 antipsychotics Drugs 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 239000002245 particle Substances 0.000 abstract 2
- 230000005494 condensation Effects 0.000 abstract 1
- 238000009833 condensation Methods 0.000 abstract 1
- 238000010438 heat treatment Methods 0.000 abstract 1
- 238000002664 inhalation therapy Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/423—Oxazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/49—Cinchonan derivatives, e.g. quinine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
- A61K31/5517—1,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/06—Inhaling appliances shaped like cigars, cigarettes or pipes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F24—HEATING; RANGES; VENTILATING
- F24V—COLLECTION, PRODUCTION OR USE OF HEAT NOT OTHERWISE PROVIDED FOR
- F24V30/00—Apparatus or devices using heat produced by exothermal chemical reactions other than combustion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
- A61M11/04—Sprayers or atomisers specially adapted for therapeutic purposes operated by the vapour pressure of the liquid to be sprayed or atomised
- A61M11/041—Sprayers or atomisers specially adapted for therapeutic purposes operated by the vapour pressure of the liquid to be sprayed or atomised using heaters
- A61M11/042—Sprayers or atomisers specially adapted for therapeutic purposes operated by the vapour pressure of the liquid to be sprayed or atomised using heaters electrical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/82—Internal energy supply devices
- A61M2205/8206—Internal energy supply devices battery-operated
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Emergency Medicine (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Dispersion Chemistry (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Mechanical Engineering (AREA)
- Physics & Mathematics (AREA)
- Heart & Thoracic Surgery (AREA)
- General Engineering & Computer Science (AREA)
- Otolaryngology (AREA)
- Addiction (AREA)
- Combustion & Propulsion (AREA)
- Thermal Sciences (AREA)
- Hematology (AREA)
- Gynecology & Obstetrics (AREA)
- Psychology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Immunology (AREA)
- Reproductive Health (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US29420301P | 2001-05-24 | 2001-05-24 | |
US31747901P | 2001-09-05 | 2001-09-05 | |
PCT/US2002/016118 WO2002094236A1 (en) | 2001-05-24 | 2002-05-20 | Delivery of antipsychotics through an inhalation route |
Publications (1)
Publication Number | Publication Date |
---|---|
BE2013C054I2 true BE2013C054I2 (es) | 2021-07-19 |
Family
ID=30772632
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BE2013C054C BE2013C054I2 (es) | 2001-05-24 | 2013-08-19 |
Country Status (16)
Country | Link |
---|---|
US (75) | US6737042B2 (es) |
EP (14) | EP1392262A1 (es) |
JP (7) | JP2005503425A (es) |
AT (11) | ATE401064T1 (es) |
AU (3) | AU2002314784A1 (es) |
BE (1) | BE2013C054I2 (es) |
CA (7) | CA2446904A1 (es) |
DE (4) | DE60235851D1 (es) |
DK (1) | DK1389098T3 (es) |
ES (5) | ES2312571T3 (es) |
FR (1) | FR13C0051I1 (es) |
MX (2) | MXPA03010703A (es) |
NZ (6) | NZ529422A (es) |
PL (3) | PL363996A1 (es) |
PT (2) | PT1389098E (es) |
WO (1) | WO2002094236A1 (es) |
Families Citing this family (375)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030203036A1 (en) * | 2000-03-17 | 2003-10-30 | Gordon Marc S. | Systems and processes for spray drying hydrophobic drugs with hydrophilic excipients |
US7632517B2 (en) * | 1997-10-01 | 2009-12-15 | Novadel Pharma Inc. | Buccal, polar and non-polar spray containing zolpidem |
US7087215B2 (en) * | 1998-12-21 | 2006-08-08 | Generex Pharmaceuticals Incorporated | Methods of administering and enhancing absorption of pharmaceutical agents |
US7258850B2 (en) * | 1999-05-04 | 2007-08-21 | Aradigm Corporation | Methods and compositions for treating erectile dysfunction |
AU777257B2 (en) * | 1999-07-12 | 2004-10-07 | Capnia Incorporated | Methods and apparatus for relieving headaches, rhinitis and other common ailments |
US20060172017A1 (en) | 1999-11-08 | 2006-08-03 | Capnia, Incorporated | Methods and apparatus for the enhanced delivery of physiologic agents to tissue surfaces |
WO2001036018A2 (en) * | 1999-11-08 | 2001-05-25 | Capnia Incorporated | Method and apparatus for relieving ailments using gases to increase the effectiveness of drugs |
US20070039615A1 (en) * | 1999-11-08 | 2007-02-22 | Capnia, Incorporated | Methods and apparatus for treating rhinitis |
EP1233651A1 (en) * | 2000-04-07 | 2002-08-21 | Ibiden Co., Ltd. | Ceramic heater |
US20040115133A1 (en) * | 2000-05-10 | 2004-06-17 | Wermeling Daniel P. | Intranasal opioid compositions |
AU2001277230A1 (en) * | 2000-08-01 | 2002-02-13 | Inhale Therapeutic Systems, Inc. | Apparatus and process to produce particles having a narrow size distribution andparticles made thereby |
US20020169507A1 (en) | 2000-12-14 | 2002-11-14 | David Malone | Interbody spine fusion cage |
SE0101204D0 (sv) * | 2001-04-04 | 2001-04-04 | Siemens Elema Ab | Heating device for respiration gas |
US7645442B2 (en) | 2001-05-24 | 2010-01-12 | Alexza Pharmaceuticals, Inc. | Rapid-heating drug delivery article and method of use |
EP1392262A1 (en) | 2001-05-24 | 2004-03-03 | Alexza Molecular Delivery Corporation | Delivery of drug esters through an inhalation route |
US7498019B2 (en) | 2001-05-24 | 2009-03-03 | Alexza Pharmaceuticals, Inc. | Delivery of compounds for the treatment of headache through an inhalation route |
US7458374B2 (en) | 2002-05-13 | 2008-12-02 | Alexza Pharmaceuticals, Inc. | Method and apparatus for vaporizing a compound |
US7090830B2 (en) * | 2001-05-24 | 2006-08-15 | Alexza Pharmaceuticals, Inc. | Drug condensation aerosols and kits |
US7078016B2 (en) * | 2001-11-21 | 2006-07-18 | Alexza Pharmaceuticals, Inc. | Delivery of caffeine through an inhalation route |
US7766013B2 (en) * | 2001-06-05 | 2010-08-03 | Alexza Pharmaceuticals, Inc. | Aerosol generating method and device |
US20070122353A1 (en) | 2001-05-24 | 2007-05-31 | Hale Ron L | Drug condensation aerosols and kits |
US6805853B2 (en) | 2001-11-09 | 2004-10-19 | Alexza Molecular Delivery Corporation | Delivery of diazepam through an inhalation route |
WO2002094242A1 (en) | 2001-05-24 | 2002-11-28 | Alexza Molecular Delivery Corporation | Delivery of rizatriptan or zolmitriptan through an inhalation route |
US6737043B2 (en) | 2001-05-24 | 2004-05-18 | Alexza Molecula Delivery Corporation | Delivery of alprazolam, estazolam, midazolam or triazolam through an inhalation route |
GB0208742D0 (en) | 2002-04-17 | 2002-05-29 | Bradford Particle Design Ltd | Particulate materials |
EP1455875A2 (en) * | 2001-11-21 | 2004-09-15 | Alexza Molecular Delivery Corporation | Open-celled substrates for drug delivery |
US7523065B2 (en) * | 2001-12-12 | 2009-04-21 | Asset Trust, Inc. | Risk transfer supply chain system |
GB2384184B (en) * | 2002-01-10 | 2005-01-12 | Aea Technology Plc | Cannabis aerosol |
US7582284B2 (en) * | 2002-04-17 | 2009-09-01 | Nektar Therapeutics | Particulate materials |
GB0216562D0 (en) * | 2002-04-25 | 2002-08-28 | Bradford Particle Design Ltd | Particulate materials |
US9339459B2 (en) | 2003-04-24 | 2016-05-17 | Nektar Therapeutics | Particulate materials |
EP1503744A1 (en) * | 2002-05-13 | 2005-02-09 | Alexza Molecular Delivery Corporation | Delivery of drug amines through an inhalation route |
US20060193788A1 (en) * | 2002-11-26 | 2006-08-31 | Hale Ron L | Acute treatment of headache with phenothiazine antipsychotics |
EP1519720A4 (en) * | 2002-06-10 | 2010-02-10 | Wyeth Corp | NOVEL O-DESMETHYLVENLAFAXINE FORMALITY SALT |
DE10234165B4 (de) * | 2002-07-26 | 2008-01-03 | Advanced Micro Devices, Inc., Sunnyvale | Verfahren zum Füllen eines Grabens, der in einem Substrat gebildet ist, mit einem isolierenden Material |
US20040076671A1 (en) * | 2002-10-21 | 2004-04-22 | Aletha Tippett | Methods and compositions for topical wound treatment |
US7644715B2 (en) * | 2002-10-31 | 2010-01-12 | Cooltouch, Incorporated | Restless leg syndrome treatment |
US20040105818A1 (en) | 2002-11-26 | 2004-06-03 | Alexza Molecular Delivery Corporation | Diuretic aerosols and methods of making and using them |
MXPA05005609A (es) * | 2002-11-26 | 2005-07-26 | Alexza Pharmaceuticals Inc | Tratamiento de dolor de cabeza con antipsicoticos suministrados por inhalacion. |
US7550133B2 (en) * | 2002-11-26 | 2009-06-23 | Alexza Pharmaceuticals, Inc. | Respiratory drug condensation aerosols and methods of making and using them |
CN101371843B (zh) * | 2002-11-26 | 2012-09-26 | 艾利斯达医药品公司 | 洛沙平和阿莫沙平在制备治疗疼痛的药物中的应用 |
US7913688B2 (en) | 2002-11-27 | 2011-03-29 | Alexza Pharmaceuticals, Inc. | Inhalation device for producing a drug aerosol |
US7501113B2 (en) * | 2003-02-04 | 2009-03-10 | Philip Morris Usa Inc. | Aerosol formulations and aerosol delivery of buprenorphine |
US7648981B2 (en) * | 2003-02-28 | 2010-01-19 | Ym Biosciences Inc. | Opioid delivery system |
WO2005082369A1 (en) * | 2003-02-28 | 2005-09-09 | Delex Therapeutics Inc. | Opioid delivery system |
US7648982B2 (en) * | 2003-02-28 | 2010-01-19 | Ym Biosciences Inc. | Opioid delivery system |
EP1603533B1 (en) * | 2003-02-28 | 2009-04-15 | YM Biosciences Inc. | Opioid delivery system |
BRPI0409380A (pt) * | 2003-04-14 | 2006-04-18 | Vectura Ltd | composições farmacêuticas |
US20040204439A1 (en) * | 2003-04-14 | 2004-10-14 | Staniforth John Nicholas | Composition, device, and method for treating sexual dysfunction via inhalation |
ATE510174T1 (de) * | 2003-05-21 | 2011-06-15 | Alexza Pharmaceuticals Inc | Schlag gezündete unabhängige heizeinheit |
GB0314149D0 (en) * | 2003-06-18 | 2003-07-23 | Generics Uk Ltd | Novel amorphous forms |
US20040265238A1 (en) * | 2003-06-27 | 2004-12-30 | Imtiaz Chaudry | Inhalable formulations for treating pulmonary hypertension and methods of using same |
CN2718561Y (zh) * | 2003-07-11 | 2005-08-17 | 艾康生物技术(杭州)有限公司 | 用于取样签的保护套 |
NZ527142A (en) * | 2003-07-23 | 2006-03-31 | Douglas Pharmaceuticals Ltd | A stable suspension formulation |
US20050042177A1 (en) * | 2003-07-23 | 2005-02-24 | Elan Pharma International Ltd. | Novel compositions of sildenafil free base |
US20050037506A1 (en) * | 2003-08-04 | 2005-02-17 | Alexza Molecular Delivery Corporation | Methods of determining film thicknesses for an aerosol delivery article |
EP1656171B9 (en) * | 2003-08-04 | 2010-10-20 | Alexza Pharmaceuticals, Inc. | Substrates for drug delivery device and methods of preparing |
CA2538237A1 (en) * | 2003-09-10 | 2005-03-24 | Map Pharmaceuticals, Inc. | Aerosol formulations for delivery of dihydroergotamine to the systemic circulation via pulmonary inhalation |
BRPI0414428A (pt) * | 2003-09-15 | 2006-11-14 | Vectura Ltd | composições farmacêuticas |
GB2407498B (en) * | 2003-10-30 | 2008-06-11 | Cipla Ltd | Oral formulations for 5-HT receptor agonists with reduced degradation of active ingredient |
CN1305266C (zh) * | 2003-12-19 | 2007-03-14 | 深圳国人通信有限公司 | 基于嵌入式系统的无线局域网接入点设备 |
US20050171088A1 (en) * | 2004-01-30 | 2005-08-04 | Astrazeneca Ab | Treatment of psychoses with dibenzothiazepine antipsychotic |
US20050256553A1 (en) * | 2004-02-09 | 2005-11-17 | John Strisower | Method and apparatus for the treatment of respiratory and other infections using ultraviolet germicidal irradiation |
JP4440966B2 (ja) * | 2004-03-04 | 2010-03-24 | ユーティーシダカントンシュンヨウシャンゴンシ | 無線基地局におけるロード共有方法及びシステム |
US7422224B2 (en) * | 2004-04-13 | 2008-09-09 | Kimir Seatpost | Adjustable bicycle seat post assembly |
US7402777B2 (en) * | 2004-05-20 | 2008-07-22 | Alexza Pharmaceuticals, Inc. | Stable initiator compositions and igniters |
US7540286B2 (en) | 2004-06-03 | 2009-06-02 | Alexza Pharmaceuticals, Inc. | Multiple dose condensation aerosol devices and methods of forming condensation aerosols |
US20100006092A1 (en) * | 2004-08-12 | 2010-01-14 | Alexza Pharmaceuticals, Inc. | Aerosol Drug Delivery Device Incorporating Percussively Activated Heat Packages |
US20060039869A1 (en) * | 2004-08-17 | 2006-02-23 | Daniel Wermeling | Intranasal delivery of antipsychotic drugs |
WO2006044421A2 (en) * | 2004-10-12 | 2006-04-27 | Alexza Pharmaceuticals, Inc. | Cardiac safe, rapid medication delivery |
GB0425758D0 (en) | 2004-11-23 | 2004-12-22 | Vectura Ltd | Preparation of pharmaceutical compositions |
ZA200706613B (en) * | 2004-12-16 | 2009-03-25 | Cipla Ltd | Process |
US20060130829A1 (en) * | 2004-12-20 | 2006-06-22 | Sexton Douglas A | Inhalation device |
US7827983B2 (en) * | 2004-12-20 | 2010-11-09 | Hewlett-Packard Development Company, L.P. | Method for making a pharmaceutically active ingredient abuse-prevention device |
EP1879874A2 (en) | 2005-04-21 | 2008-01-23 | Medichem, S.A. | Process for preparing quetiapine and quetiapine fumarate |
US20090117660A1 (en) * | 2005-04-30 | 2009-05-07 | Oakville Hong Kong Co., Limited | Devices and methods for sample collection and analysis |
US8062901B2 (en) * | 2005-04-30 | 2011-11-22 | Alere Switzerland Gmbh | Devices and methods for sample collection and analysis |
RU2408368C2 (ru) | 2005-06-27 | 2011-01-10 | Биовэйл Лэборэториз Интернэшнл С.Р.Л. | Препараты соли бупропиона с модифицированным высвобождением |
JP2009502961A (ja) | 2005-07-29 | 2009-01-29 | コンサート ファーマシューティカルズ インコーポレイテッド | 新規な医薬組成物 |
US20070104792A1 (en) * | 2005-09-13 | 2007-05-10 | Elan Pharma International, Limited | Nanoparticulate tadalafil formulations |
US20070092401A1 (en) * | 2005-10-26 | 2007-04-26 | Feier Liao | Devices and methods for sample collection and analysis |
CA2632209C (en) * | 2005-12-01 | 2015-09-29 | Vapore, Inc. | Advanced capillary force vaporizers |
US8252328B2 (en) | 2006-01-06 | 2012-08-28 | Acelrx Pharmaceuticals, Inc. | Bioadhesive drug formulations for oral transmucosal delivery |
US8753308B2 (en) | 2006-01-06 | 2014-06-17 | Acelrx Pharmaceuticals, Inc. | Methods for administering small volume oral transmucosal dosage forms using a dispensing device |
US8535714B2 (en) | 2006-01-06 | 2013-09-17 | Acelrx Pharmaceuticals, Inc. | Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain |
US8252329B2 (en) | 2007-01-05 | 2012-08-28 | Acelrx Pharmaceuticals, Inc. | Bioadhesive drug formulations for oral transmucosal delivery |
US8357114B2 (en) | 2006-01-06 | 2013-01-22 | Acelrx Pharmaceuticals, Inc. | Drug dispensing device with flexible push rod |
US8865743B2 (en) | 2006-01-06 | 2014-10-21 | Acelrx Pharmaceuticals, Inc. | Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain |
US9289583B2 (en) | 2006-01-06 | 2016-03-22 | Acelrx Pharmaceuticals, Inc. | Methods for administering small volume oral transmucosal dosage forms using a dispensing device |
US9066847B2 (en) | 2007-01-05 | 2015-06-30 | Aceirx Pharmaceuticals, Inc. | Storage and dispensing devices for administration of oral transmucosal dosage forms |
US8202535B2 (en) | 2006-01-06 | 2012-06-19 | Acelrx Pharmaceuticals, Inc. | Small-volume oral transmucosal dosage forms |
EP3546000A1 (en) | 2006-01-19 | 2019-10-02 | Optinose AS | Nasal administration |
US20070183351A1 (en) * | 2006-02-03 | 2007-08-09 | Motorola, Inc. | Method and apparatus for providing service in a multi-ran communication network |
WO2007123945A2 (en) * | 2006-04-21 | 2007-11-01 | Aradigm Corporation | Mechanical single dose intrapulmonary drug delivery devices |
US7909033B2 (en) | 2006-05-03 | 2011-03-22 | Comedica Incorporated | Breathing treatment apparatus |
US8536445B2 (en) * | 2006-06-02 | 2013-09-17 | Emcore Solar Power, Inc. | Inverted metamorphic multijunction solar cells |
US20070299687A1 (en) * | 2006-06-23 | 2007-12-27 | Pamela Palmer | Inpatient system for patient-controlled delivery of oral transmucosal medications dosed as needed |
US8051854B2 (en) * | 2006-09-15 | 2011-11-08 | Comedica Incorporated | Continuous high-frequency oscillation breathing treatment apparatus |
GB0620661D0 (en) * | 2006-10-18 | 2006-11-29 | Pharmasol Ltd | Novel compounds |
US20090270438A1 (en) * | 2006-10-18 | 2009-10-29 | Clive Booles | Novel compositions and formulations |
US20080102097A1 (en) * | 2006-10-31 | 2008-05-01 | Zanella John M | Device and method for treating osteolysis using a drug depot to deliver an anti-inflammatory agent |
US8279765B2 (en) * | 2006-11-13 | 2012-10-02 | Motorola Solutions, Inc. | Method and apparatus for interworking in an inter-technology network |
US20080154374A1 (en) * | 2006-12-20 | 2008-06-26 | Robert David Labrom | Joint implant and a surgical method associated therewith |
US20080299048A1 (en) * | 2006-12-22 | 2008-12-04 | Alexza Pharmaceuticals, Inc. | Mixed drug aerosol compositions |
US20080275030A1 (en) | 2007-01-19 | 2008-11-06 | Sveinbjorn Gizurarson | Methods and Compositions for the Delivery of a Therapeutic Agent |
KR20150041804A (ko) | 2007-02-11 | 2015-04-17 | 맵 파마슈티컬스, 인코포레이티드 | 부작용 프로파일을 최소화하면서 편두통의 빠른 완화를 가능하게 하는 dhe의 치료적 투여 방법 |
ES2594867T3 (es) | 2007-03-09 | 2016-12-23 | Alexza Pharmaceuticals, Inc. | Unidad de calentamiento para usar en un dispositivo de administración de fármaco |
ES2559838T3 (es) | 2007-03-16 | 2016-02-16 | Concert Pharmaceuticals, Inc. | Inhibidores de proteína de transferencia de ésteres de colesterol |
WO2008116165A2 (en) * | 2007-03-21 | 2008-09-25 | Next Safety, Inc. | Methods and systems of delivering medication via inhalation |
US20080261926A1 (en) * | 2007-04-02 | 2008-10-23 | Liu Julie F | Pharmaceutical Calcimimetics |
GB2448183A (en) * | 2007-04-05 | 2008-10-08 | Optinose As | Nasal powder delivery device |
WO2008124585A1 (en) * | 2007-04-06 | 2008-10-16 | Board Of Governors For Higher Education, State Of Rhode Island And Providence Planations | Lowering of proteins associated with alzheimer's disease by interrupting gene transcription with a small molecule |
WO2008128166A1 (en) * | 2007-04-13 | 2008-10-23 | Concert Pharmaceuticals Inc. | Deuterated derivatives of 4-(6-fluoro-1, 2-benzisoxazol-3-yl) piperidine compounds |
JP2010524972A (ja) * | 2007-04-19 | 2010-07-22 | コンサート ファーマシューティカルズ インコーポレイテッド | 重水素化したモルホリニル化合物 |
ES2401914T3 (es) | 2007-04-25 | 2013-04-25 | Concert Pharmaceuticals Inc. | Análogos de Cilostazol |
US7608737B2 (en) | 2007-05-01 | 2009-10-27 | Concert Pharmaceuticasl Inc. | Naphthyl(ethyl)acetamides |
MX341177B (es) | 2007-05-01 | 2016-08-10 | Concert Pharmaceuticals Inc | Compuestos de morfina. |
PT2345653E (pt) | 2007-05-01 | 2013-04-01 | Concert Pharmaceuticals Inc | Compostos de morfinano |
HUE063526T2 (hu) | 2007-05-01 | 2024-01-28 | Concert Pharmaceuticals Ind Inc | Morfinvegyületek |
WO2008141021A1 (en) * | 2007-05-08 | 2008-11-20 | Concert Pharmaceuticals, Inc. | Deuterated derivatives of tetrahydrotriazolopyrazine compounds and their use as dpp-iv inhibitors |
US9050434B2 (en) * | 2007-05-18 | 2015-06-09 | Comedica Incorporated | Lung therapy device |
ES2356334T3 (es) | 2007-06-12 | 2011-04-07 | Concert Pharmaceuticals, Inc. | Derivados de azapéptidos como inhibidores de la proteasa vih. |
WO2009009531A2 (en) * | 2007-07-09 | 2009-01-15 | Concert Pharmaceuticals Inc. | Pyrimidinecarboxamide derivatives for the treatment of hiv infections |
US8442390B2 (en) * | 2007-08-29 | 2013-05-14 | Philip Morris Usa Inc. | Pulsed aerosol generation |
CA2698808A1 (en) | 2007-09-13 | 2009-03-19 | Concert Pharmaceuticals, Inc. | Synthesis of deuterated catechols and benzo[d][1,3] dioxoles and derivatives thereof |
US8470360B2 (en) | 2008-04-18 | 2013-06-25 | Warsaw Orthopedic, Inc. | Drug depots having different release profiles for reducing, preventing or treating pain and inflammation |
US20090104964A1 (en) * | 2007-10-17 | 2009-04-23 | Igt | Gaming system, gaming device and gaming method providing player physical activation of the symbol generator |
US8410124B2 (en) * | 2007-10-18 | 2013-04-02 | Concert Pharmaceuticals Inc. | Deuterated etravirine |
GB0721394D0 (en) * | 2007-10-31 | 2007-12-12 | Vectura Group Plc | Compositions for trating parkinson's disease |
US20090162421A1 (en) * | 2007-12-21 | 2009-06-25 | Paz Arzneimittel-Entwicklungsgesellschaft Mbh | Drugs as well as their production and use in the treatment of pain-associated neuropathies |
US9138430B2 (en) * | 2007-12-27 | 2015-09-22 | Mylan Specialty L.P. | Formulation and method for the release of paroxetine in the large intestine |
EP2262502A4 (en) * | 2008-02-05 | 2011-12-28 | Clera Inc | COMPOSITIONS AND METHODS FOR RELIEVING DEPRESSION OR ENHANCING COGNITIVE PROCESSES |
EP3272379A1 (en) | 2008-02-07 | 2018-01-24 | The University of Washington | Circumferential aerosol device |
BRPI0908107A2 (pt) | 2008-02-29 | 2019-09-24 | Concert Pharmaceuticals Inc | composto derivado de xantina substituída, composição farmacêutica que compreende esse composto, métodos de tratamento de uma enfermidade ou condição em um paciente com necessidade do mesmo, método de tratamento de enfermidade crônica dos rins, do fígado, relacionada com diabetes e de claudicação intermitente |
EP3246034A1 (en) | 2008-03-06 | 2017-11-22 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules as anti-inflammatory agents |
US8201752B2 (en) * | 2008-03-10 | 2012-06-19 | Vapore, Inc. | Low energy vaporization of liquids: apparatus and methods |
US8883768B2 (en) * | 2008-04-18 | 2014-11-11 | Warsaw Orthopedic, Inc. | Fluocinolone implants to protect against undesirable bone and cartilage destruction |
US8889173B2 (en) * | 2008-04-18 | 2014-11-18 | Warsaw Orthopedic, Inc. | Alpha adrenergic receptor agonists for treatment of pain and/or inflammation |
US8420114B2 (en) * | 2008-04-18 | 2013-04-16 | Warsaw Orthopedic, Inc. | Alpha and beta adrenergic receptor agonists for treatment of pain and / or inflammation |
US8722079B2 (en) | 2008-04-18 | 2014-05-13 | Warsaw Orthopedic, Inc. | Methods for treating conditions such as dystonia and post-stroke spasticity with clonidine |
USRE48948E1 (en) | 2008-04-18 | 2022-03-01 | Warsaw Orthopedic, Inc. | Clonidine compounds in a biodegradable polymer |
US8557273B2 (en) | 2008-04-18 | 2013-10-15 | Medtronic, Inc. | Medical devices and methods including polymers having biologically active agents therein |
US9610243B2 (en) | 2008-04-18 | 2017-04-04 | Warsaw Orthopedic, Inc. | Clonidine compounds in a biodegradable polymer |
US8946277B2 (en) | 2008-04-18 | 2015-02-03 | Warsaw Orthopedic, Inc. | Clonidine formulations in a biodegradable polymer carrier |
US9132085B2 (en) * | 2008-04-18 | 2015-09-15 | Warsaw Orthopedic, Inc. | Compositions and methods for treating post-operative pain using clonidine and bupivacaine |
US20090264489A1 (en) * | 2008-04-18 | 2009-10-22 | Warsaw Orthopedic, Inc. | Method for Treating Acute Pain with a Formulated Drug Depot in Combination with a Liquid Formulation |
US20090263451A1 (en) * | 2008-04-18 | 2009-10-22 | Warsaw Orthopedic, Inc. | Anti-Inflammatory and/or Analgesic Agents for Treatment of Myofascial Pain |
US8956641B2 (en) * | 2008-04-18 | 2015-02-17 | Warsaw Orthopedic, Inc. | Alpha adrenergic receptor agonists for treatment of inflammatory diseases |
US20090263489A1 (en) * | 2008-04-18 | 2009-10-22 | Warsaw Orthopedic, Inc. | Analgesic and anti-inflammatory compositions and methods for reducing, preventing or treating pain and inflammation |
US8629172B2 (en) * | 2008-04-18 | 2014-01-14 | Warsaw Orthopedic, Inc. | Methods and compositions for treating post-operative pain comprising clonidine |
US9072727B2 (en) * | 2008-04-18 | 2015-07-07 | Warsaw Orthopedic, Inc. | Alpha adrenergic receptor agonists for treatment of degenerative disc disease |
US9132119B2 (en) * | 2008-04-18 | 2015-09-15 | Medtronic, Inc. | Clonidine formulation in a polyorthoester carrier |
US20090264477A1 (en) * | 2008-04-18 | 2009-10-22 | Warsaw Orthopedic, Inc., An Indiana Corporation | Beta adrenergic receptor agonists for treatment of pain and/or inflammation |
US9662391B2 (en) | 2008-04-24 | 2017-05-30 | The Invention Science Fund I Llc | Side effect ameliorating combination therapeutic products and systems |
US9282927B2 (en) | 2008-04-24 | 2016-03-15 | Invention Science Fund I, Llc | Methods and systems for modifying bioactive agent use |
US9449150B2 (en) | 2008-04-24 | 2016-09-20 | The Invention Science Fund I, Llc | Combination treatment selection methods and systems |
US20100017001A1 (en) * | 2008-04-24 | 2010-01-21 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Computational system and method for memory modification |
US9560967B2 (en) | 2008-04-24 | 2017-02-07 | The Invention Science Fund I Llc | Systems and apparatus for measuring a bioactive agent effect |
US9649469B2 (en) | 2008-04-24 | 2017-05-16 | The Invention Science Fund I Llc | Methods and systems for presenting a combination treatment |
PT2293794E (pt) * | 2008-05-27 | 2013-07-10 | Univ Melbourne | Métodos de tratamento de mamíferos com disfunções da trompa de eustáquio |
US7845277B2 (en) * | 2008-05-28 | 2010-12-07 | Autoliv Asp, Inc. | Header assembly |
WO2009146310A1 (en) * | 2008-05-28 | 2009-12-03 | Concert Pharmaceuticals Inc. | Deuterated tizanidine |
US20100221221A1 (en) * | 2008-08-12 | 2010-09-02 | Concert Pharmaceuticals Inc. | N-phenyl-2-pyrimidineamine derivatives |
US20110190323A1 (en) * | 2008-08-28 | 2011-08-04 | President And Fellows Of Harvard College | Cortistatin analogues and syntheses thereof |
US7834295B2 (en) | 2008-09-16 | 2010-11-16 | Alexza Pharmaceuticals, Inc. | Printable igniters |
US20100065052A1 (en) * | 2008-09-16 | 2010-03-18 | Alexza Pharmaceuticals, Inc. | Heating Units |
AU2009293123B2 (en) | 2008-09-19 | 2013-12-19 | Concert Pharmaceuticals Inc. | Morphinan compounds |
US20100098746A1 (en) * | 2008-10-20 | 2010-04-22 | Warsaw Orthopedic, Inc. | Compositions and methods for treating periodontal disease comprising clonidine, sulindac and/or fluocinolone |
HUE028956T2 (en) | 2008-10-30 | 2017-01-30 | Concert Pharmaceuticals Inc | A combination of morphine compounds and an antidepressant for the treatment of pseudobulbar effects |
EP2364151A1 (en) | 2008-10-30 | 2011-09-14 | Concert Pharmaceuticals Inc. | Combination of morphinan compounds and antidepressant for the treatment of pseudobulbar affect, neurological diseases, intractable and chronic pain and brain injury |
US8198268B2 (en) * | 2008-10-31 | 2012-06-12 | Janssen Biotech, Inc. | Tianeptine sulfate salt forms and methods of making and using the same |
AU2009311645C1 (en) | 2008-11-04 | 2014-10-02 | Acer Therapeutics Inc. | CXCR4 receptor compounds |
US8945592B2 (en) | 2008-11-21 | 2015-02-03 | Acelrx Pharmaceuticals, Inc. | Sufentanil solid dosage forms comprising oxygen scavengers and methods of using the same |
WO2010065547A1 (en) * | 2008-12-01 | 2010-06-10 | Map Pharmaceuticals, Inc. | Inhalation delivery methods and devices |
US8822546B2 (en) * | 2008-12-01 | 2014-09-02 | Medtronic, Inc. | Flowable pharmaceutical depot |
US20110313004A1 (en) | 2008-12-04 | 2011-12-22 | Concert Pharmaceuticals, Inc. | Deuterated pyridinones |
US8555875B2 (en) * | 2008-12-23 | 2013-10-15 | Map Pharmaceuticals, Inc. | Inhalation devices and related methods for administration of sedative hypnotic compounds |
US20100163033A1 (en) * | 2008-12-30 | 2010-07-01 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Methods and systems for presenting an inhalation experience |
US8694330B2 (en) * | 2008-12-30 | 2014-04-08 | The Invention Science Fund I, Llc | Methods and systems for presenting an inhalation experience |
US20100168525A1 (en) * | 2008-12-30 | 2010-07-01 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Methods and systems for presenting an inhalation experience |
US20100169260A1 (en) * | 2008-12-30 | 2010-07-01 | Searete Llc | Methods and systems for presenting an inhalation experience |
US20100163024A1 (en) * | 2008-12-30 | 2010-07-01 | Searete Llc, A Limited Liability Corporation | Methods and systems for presenting an inhalation experience |
US20100166613A1 (en) * | 2008-12-30 | 2010-07-01 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Methods and systems for presenting an inhalation experience |
US20100163034A1 (en) * | 2008-12-30 | 2010-07-01 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Methods and systems for presenting an inhalation experience |
US20100163027A1 (en) * | 2008-12-30 | 2010-07-01 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Methods and systems for presenting an inhalation experience |
US8738395B2 (en) * | 2008-12-30 | 2014-05-27 | The Invention Science Fund I, Llc | Methods and systems for presenting an inhalation experience |
US20100163038A1 (en) * | 2008-12-30 | 2010-07-01 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Methods and systems for presenting an inhalation experience |
US20100163036A1 (en) * | 2008-12-30 | 2010-07-01 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Methods and systems for presenting an inhalation experience |
US20100169259A1 (en) * | 2008-12-30 | 2010-07-01 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Methods and systems for presenting an inhalation experience |
US20100168602A1 (en) * | 2008-12-30 | 2010-07-01 | Searete Llc | Methods and systems for presenting an inhalation experience |
US8706518B2 (en) * | 2008-12-30 | 2014-04-22 | The Invention Science Fund I, Llc | Methods and systems for presenting an inhalation experience |
US8725529B2 (en) | 2008-12-30 | 2014-05-13 | The Invention Science Fund I, Llc | Methods and systems for presenting an inhalation experience |
US20100168529A1 (en) * | 2008-12-30 | 2010-07-01 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Methods and systems for presenting an inhalation experience |
US20100163025A1 (en) * | 2008-12-30 | 2010-07-01 | Searete Llc | Methods and systems for presenting an inhalation experience |
US8712794B2 (en) * | 2008-12-30 | 2014-04-29 | The Invention Science Fund I, Llc | Methods and systems for presenting an inhalation experience |
US20110053961A1 (en) | 2009-02-27 | 2011-03-03 | Concert Pharmaceuticals, Inc. | Substituted xanthine derivatives |
US20100228097A1 (en) * | 2009-03-04 | 2010-09-09 | Warsaw Orthopedic, Inc. | Methods and compositions to diagnose pain |
EP2229980B1 (en) * | 2009-03-16 | 2015-08-12 | Nuvolase, Inc. | Treatment of microbiological pathogens in a toe nail with antimicrobial light |
US8563554B2 (en) | 2009-03-17 | 2013-10-22 | Concert Pharmaceuticals, Inc. | Deuterated pyrazinoisoquinoline compounds |
WO2010107964A1 (en) * | 2009-03-18 | 2010-09-23 | Pleiades Cardio-Therapeutics, Inc. | Unit doses, aerosols, kits, and methods for treating heart conditions by pulmonary administration |
WO2010107761A1 (en) | 2009-03-18 | 2010-09-23 | Acelrx Pharmaceuticals, Inc. | Improved storage and dispensing devices for administration of oral transmucosal dosage forms |
US20100239632A1 (en) * | 2009-03-23 | 2010-09-23 | Warsaw Orthopedic, Inc. | Drug depots for treatment of pain and inflammation in sinus and nasal cavities or cardiac tissue |
US20120244122A1 (en) | 2009-05-28 | 2012-09-27 | Masse Craig E | Peptides for the Treatment of HCV Infections |
US20100300433A1 (en) * | 2009-05-28 | 2010-12-02 | Alexza Pharmaceuticals, Inc. | Substrates for Enhancing Purity or Yield of Compounds Forming a Condensation Aerosol |
ES2469849T3 (es) | 2009-06-18 | 2014-06-20 | Concert Pharmaceuticals Inc. | Derivados deuterados de isoindolin-1,3-diona como inhibidores de PDE4 y TNF-alfa |
US8501738B2 (en) | 2009-06-23 | 2013-08-06 | Concert Pharmaceuticals, Inc. | Substituted triazolo-pyridazine derivatives |
US20110171141A1 (en) * | 2009-06-26 | 2011-07-14 | Kellerman Donald J | Administration of dihydroergotamine mesylate particles using a metered dose inhaler |
US8617583B2 (en) * | 2009-07-17 | 2013-12-31 | Warsaw Orthopedic, Inc. | Alpha adrenergic receptor agonists for prevention or treatment of a hematoma, edema, and/or deep vein thrombosis |
US20110015154A1 (en) * | 2009-07-20 | 2011-01-20 | Kellermann Gottfried H | Supporting acetylcholine function |
US8814922B2 (en) * | 2009-07-22 | 2014-08-26 | New Star Lasers, Inc. | Method for treatment of fingernail and toenail microbial infections using infrared laser heating and low pressure |
US8231891B2 (en) * | 2009-07-31 | 2012-07-31 | Warsaw Orthopedic, Inc. | Implantable drug depot for weight control |
US10758582B2 (en) * | 2009-08-17 | 2020-09-01 | Xten Capital Group, Inc. | Vaporized medicants and methods of use |
EP3336543A1 (en) * | 2009-09-09 | 2018-06-20 | Sensa Bues AB | Drug detection in exhaled breath |
ES2911336T3 (es) | 2009-10-13 | 2022-05-18 | Philip Morris Products Sa | Generador de aerosol |
US8278460B2 (en) | 2009-10-15 | 2012-10-02 | Concert Pharmaceuticals, Inc. | Substituted benzimidazoles |
US20110097375A1 (en) | 2009-10-26 | 2011-04-28 | Warsaw Orthopedic, Inc. | Formulation for preventing or reducing bleeding at a surgical site |
US20110098265A1 (en) * | 2009-10-28 | 2011-04-28 | Neuroscience, Inc. | Methods for reducing cravings and impulses associated with addictive and compulsive behaviors |
US20110100360A1 (en) * | 2009-11-02 | 2011-05-05 | Joseph Dee Faram | Composite lung therapy device and method |
US9151425B2 (en) * | 2009-11-02 | 2015-10-06 | Comedica Incorporated | Multiple conduit connector apparatus and method |
WO2011094450A1 (en) | 2010-01-27 | 2011-08-04 | Anacor Pharmaceuticals, Inc | Boron-containing small molecules |
EP2536696A1 (en) | 2010-02-18 | 2012-12-26 | Concert Pharmaceuticals Inc. | Pyrimidine derivatives |
EP2566494B1 (en) | 2010-02-26 | 2017-11-29 | Acer Therapeutics, Inc. | Cxcr4 receptor compounds |
US8575361B2 (en) | 2010-03-02 | 2013-11-05 | Concert Pharmaceuticals Inc. | Tetrahydronaphthalene derivatives |
US8513434B2 (en) | 2010-03-02 | 2013-08-20 | Concert Pharmaceuticals Inc. | Tetrahydronaphthalene derivatives |
US9107922B2 (en) | 2010-07-16 | 2015-08-18 | Concert Pharmaceuticals, Inc. | Pyrimidinecarboxamide derivatives |
WO2012024595A2 (en) * | 2010-08-20 | 2012-02-23 | University Of Washington | Circumferential aerosol device for delivering drugs to olfactory epithelium and brain |
US20120048963A1 (en) | 2010-08-26 | 2012-03-01 | Alexza Pharmaceuticals, Inc. | Heat Units Using a Solid Fuel Capable of Undergoing an Exothermic Metal Oxidation-Reduction Reaction Propagated without an Igniter |
DK2613788T3 (en) | 2010-09-07 | 2017-08-07 | Anacor Pharmaceuticals Inc | BENZOXABOROLD DERIVATIVES FOR TREATMENT OF BACTERIA INFECTIONS |
DE102010041840A1 (de) * | 2010-10-01 | 2012-04-05 | Bayerische Motoren Werke Aktiengesellschaft | Verfahren zur Herstellung einer Ventilationsbohrung in einem Lagerstuhl eines Kurbelgehäuses einer Hubkolben-Brennkraftmaschine |
WO2012079075A1 (en) | 2010-12-10 | 2012-06-14 | Concert Pharmaceuticals, Inc. | Deuterated phthalimide derivatives |
CA2822738C (en) | 2010-12-22 | 2021-06-08 | Exonoid Medical Devices Ltd. | Method and system for drug delivery |
US8447329B2 (en) | 2011-02-08 | 2013-05-21 | Longsand Limited | Method for spatially-accurate location of a device using audio-visual information |
RU2612506C2 (ru) | 2011-03-03 | 2017-03-09 | Импел Ньюрофарма Инк. | Устройство для назальной доставки лекарственных средств |
WO2012129381A1 (en) | 2011-03-22 | 2012-09-27 | Concert Pharmaceuticals Inc. | Deuterated preladenant |
US20140213553A1 (en) | 2011-05-03 | 2014-07-31 | Concert Pharmaceuticals Inc. | Carbamoylpyridone derivatives |
CA2835208C (en) | 2011-05-09 | 2019-08-20 | Impel Neuropharma, Inc. | Nozzles for nasal drug delivery |
WO2012154738A1 (en) | 2011-05-09 | 2012-11-15 | The Cleveland Clinic Foundation | Composition and method to improve intestinal health |
US20140128469A1 (en) | 2011-05-10 | 2014-05-08 | Concert Pharmaceuticals Inc. | Deuterated n-butyl bumetanide |
PT3235812T (pt) | 2011-05-18 | 2019-12-09 | Vertex Pharmaceuticals Europe Ltd | Derivados deuterados de ivacaftor |
US20150011466A1 (en) | 2012-01-09 | 2015-01-08 | Anchor Therapeutics, Inc. | APJ Receptor Compounds |
WO2013130849A1 (en) | 2012-02-29 | 2013-09-06 | Concert Pharmaceuticals, Inc. | Substituted dioxopiperidinyl phthalimide derivatives |
US20150066550A1 (en) * | 2012-03-30 | 2015-03-05 | Nec Corporation | Flow line data analysis device, system, non-transitory computer readable medium and method |
US9328113B2 (en) | 2012-04-13 | 2016-05-03 | Concert Pharmaceuticals, Inc. | Substituted xanthine derivatives |
US9249093B2 (en) | 2012-04-20 | 2016-02-02 | Concert Pharmaceuticals, Inc. | Deuterated rigosertib |
EA201492287A1 (ru) | 2012-06-15 | 2015-07-30 | Консерт Фармасьютикалс, Инк. | Дейтерированные производные руксолитиниба |
US10017445B2 (en) | 2012-07-12 | 2018-07-10 | Concert Pharmaceuticals, Inc. | Deuterated idebenone |
EP3492472A1 (en) | 2012-08-17 | 2019-06-05 | Concert Pharmaceuticals Inc. | Deuterated baricitinib with improved metabolic stability as jak1 and jak2 kinase inhibitor for treating e.g. rheumatoid arthritis |
EP2711006A1 (en) | 2012-09-21 | 2014-03-26 | Basil Rigas | Product Comprising a Nicotine-Containing Material and an Anti-Cancer Agent |
MY178621A (en) | 2012-11-19 | 2020-10-19 | Vertex Pharmaceuticals Europe Ltd | Deuterated cftr potentiators |
US10034988B2 (en) | 2012-11-28 | 2018-07-31 | Fontem Holdings I B.V. | Methods and devices for compound delivery |
US9795752B2 (en) | 2012-12-03 | 2017-10-24 | Mhs Care-Innovation, Llc | Combination respiratory therapy device, system, and method |
US12080401B2 (en) | 2012-12-03 | 2024-09-03 | Metrohealth Ventures Llc | Combination respiratory therapy device, system and method |
US9757395B2 (en) | 2012-12-20 | 2017-09-12 | Otitopic Inc. | Dry powder inhaler and methods of use |
WO2014100431A1 (en) | 2012-12-20 | 2014-06-26 | Concert Pharmaceuticals, Inc. | Deuterated alk inhibitors |
US9757529B2 (en) * | 2012-12-20 | 2017-09-12 | Otitopic Inc. | Dry powder inhaler and methods of use |
WO2014110322A2 (en) | 2013-01-11 | 2014-07-17 | Concert Pharmaceuticals, Inc. | Substituted dioxopiperidinyl phthalimide derivatives |
US9186860B2 (en) | 2013-01-28 | 2015-11-17 | Carl D. Luenser | Vaporizer kit for tobacco, medications, and the like |
WO2014150043A1 (en) | 2013-03-15 | 2014-09-25 | Concert Pharmaceuticals Inc. | Inhibitors of the enzyme udp-glucose: n-acyl-sphingosine glucosyltransferase |
EA201892726A1 (ru) | 2013-03-15 | 2019-04-30 | Консерт Фармасьютикалс, Инк. | Дейтерированный палбоциклиб |
US11554229B2 (en) | 2013-03-26 | 2023-01-17 | OptiNose Inc. | Nasal administration |
HU231191B1 (hu) | 2013-04-15 | 2021-08-30 | Szegedi Tudományegyetem | Izotóp tartalmú morfin molekulák |
CA2909954C (en) | 2013-04-28 | 2021-03-23 | Impel Neuropharma, Inc. | Medical unit dose container |
JP2016518388A (ja) | 2013-04-30 | 2016-06-23 | オティトピック インク. | 乾燥粉末配合および使用方法 |
CN104274426A (zh) | 2013-07-03 | 2015-01-14 | 陆克塞纳医药公司 | 昂丹司琼细粉、昂丹司琼气溶胶组合物及其用途 |
CN104274427A (zh) * | 2013-07-03 | 2015-01-14 | 陆克塞纳医药公司 | 格拉司琼气溶胶组合物及其用途 |
CN111249584B (zh) | 2013-07-11 | 2022-04-26 | 艾利斯达医药品公司 | 与间水杨酸形成的烟碱盐 |
WO2015009889A1 (en) | 2013-07-18 | 2015-01-22 | Concert Pharmaceuticals, Inc. | Deuterated intedanib derivatives and their use for the treatment of proliferative disorders |
WO2015010045A1 (en) | 2013-07-18 | 2015-01-22 | Anchor Therapeutics, Inc. | Apj receptor compounds |
MX348595B (es) | 2013-08-02 | 2017-06-21 | Laboratorio Raam De Sahuayo S A De C V | Composicion farmaceutica con agentes antiinflamatorios y proceso de produccion. |
US9676790B2 (en) | 2013-08-30 | 2017-06-13 | Concert Pharmaceuticals, Inc. | Substituted thienotriazolodiazapines |
US10194693B2 (en) | 2013-09-20 | 2019-02-05 | Fontem Holdings 1 B.V. | Aerosol generating device |
US9364815B2 (en) * | 2013-11-07 | 2016-06-14 | Saudi Basic Industries Corporation | Method of preparing an alumina catalyst support and catalyst for dehydrogenation reactions, and its use |
US9192570B2 (en) | 2013-12-20 | 2015-11-24 | AntiOP, Inc. | Intranasal naloxone compositions and methods of making and using same |
EP3505521A1 (en) | 2013-12-24 | 2019-07-03 | President and Fellows of Harvard College | Cortistatin analogues and syntheses and uses thereof |
KR20240051283A (ko) | 2013-12-24 | 2024-04-19 | 버지니아 커먼웰스 유니버시티 | 산소첨가된 콜레스테롤 술페이트 (ocs) 의 용도 |
US10821240B2 (en) | 2014-02-11 | 2020-11-03 | Vapor Cartridge Technology Llc | Methods and drug delivery devices using cannabis |
US9220294B2 (en) | 2014-02-11 | 2015-12-29 | Timothy McCullough | Methods and devices using cannabis vapors |
US9380813B2 (en) | 2014-02-11 | 2016-07-05 | Timothy McCullough | Drug delivery system and method |
US9993488B2 (en) | 2014-02-20 | 2018-06-12 | Otitopic Inc. | Dry powder formulations for inhalation |
AU2015229661B2 (en) * | 2014-03-10 | 2019-05-30 | Tiger Tool International Incorporated | Heating and cooling systems and methods for truck cabs |
WO2015148649A2 (en) * | 2014-03-26 | 2015-10-01 | Basil Rigas | Systems and methods for ameliorating the effects of tobacco products |
EP3129013A1 (en) * | 2014-04-10 | 2017-02-15 | Crowley, Patrick | Delivery of non-steroidal antiinflammatory agents to the brain via the nasal tract to treat neurological disorders |
WO2015179772A1 (en) | 2014-05-23 | 2015-11-26 | Concert Pharmaceuticals, Inc. | Deuterated phenylquinazolinone and phenylisoquinolinone compounds |
AU2015269247B2 (en) | 2014-06-06 | 2019-10-24 | Research Triangle Institute | Apelin receptor (APJ) agonists and uses thereof |
JP2015229527A (ja) * | 2014-06-09 | 2015-12-21 | 三光機械株式会社 | 多列式自動包装機 |
EP3160565B1 (en) | 2014-06-30 | 2021-08-18 | Syqe Medical Ltd. | Devices and systems for pulmonary delivery of active agents |
IL273507B2 (en) | 2014-06-30 | 2024-06-01 | Syqe Medical Ltd | Methods, devices and systems for administering active substances through the lungs |
BR122020018207B1 (pt) | 2014-06-30 | 2022-11-29 | Syqe Medical Ltd | Dispositivo inalador |
AU2015283593B2 (en) | 2014-06-30 | 2019-08-22 | Syqe Medical Ltd. | Drug dose cartridge for an inhaler device |
US11298477B2 (en) | 2014-06-30 | 2022-04-12 | Syqe Medical Ltd. | Methods, devices and systems for pulmonary delivery of active agents |
ES2904293T3 (es) | 2014-06-30 | 2022-04-04 | Syqe Medical Ltd | Dispositivo para vaporización e inhalación de sustancias aisladas |
US10452815B2 (en) | 2014-09-29 | 2019-10-22 | Zogenix International Limited | Control system for control of distribution of medication |
WO2016061488A1 (en) | 2014-10-17 | 2016-04-21 | Concert Pharmaceuticals, Inc. | Amine reuptake inhibitors |
WO2016073545A1 (en) | 2014-11-06 | 2016-05-12 | Concert Pharmaceuticals, Inc. | Phenyloxadiazole benzoic acids |
WO2016089814A1 (en) | 2014-12-02 | 2016-06-09 | Concert Pharmaceuticals, Inc. | Deuterated analogues of daclatasvir |
AU2015369710B2 (en) | 2014-12-23 | 2020-09-17 | Vertical Pharmaceuticals, Llc | Systems, devices and methods for dispensing oral transmucosal dosage forms |
WO2016105547A1 (en) | 2014-12-24 | 2016-06-30 | Concert Pharmaceuticals, Inc. | Deuterated dasabuvir |
WO2016109795A1 (en) | 2014-12-31 | 2016-07-07 | Concert Pharmaceuticals, Inc. | Deuterated funapide and difluorofunapide |
JP2018502889A (ja) | 2015-01-20 | 2018-02-01 | エックスオーシー ファーマシューティカルズ インコーポレイテッドXoc Pharmaceuticals, Inc | イソエルゴリン化合物およびその使用 |
BR112017015487A2 (pt) | 2015-01-20 | 2018-01-30 | Xoc Pharmaceuticals Inc | Composto; composição; método de tratamento e/ou prevenção de enxaqueca, als, doença de alzheimer, doença de parkinson, distúrbios extrapirimidais, depressão, náusea, êmese, síndrome das pernas inquietas, insônia, agressão, doença de huntington, doença cardiopulmonar, fibrogênese, hipertensão arterial pulmonar, ansiedade, dependências a drogas, distonia, parassonia ou hiperlactinemia em um indivíduo; métodos de agonização dos receptores d2, 5-ht1d, 5-ht1a e 5-ht2c, em um indivíduo; método de antagonização do receptor d3 em um indivíduo; métodos de agonização seletiva dos receptores 5 -ht1d, e 5-ht2c, método de fornecimento de atividade de antagonista funcional no receptor 5 -ht2b ou no receptor 5-ht7, ou em ambos, em um indivíduo; método de fornecimento de atividade de antagonista funcional nos receptores adrenérgicos em um indivíduo |
WO2016118540A1 (en) * | 2015-01-20 | 2016-07-28 | Xoc Pharmaceuticals, Inc. | Treating and/or preventing emesis and/or nausea including acute and/or delayed nausea and/or emesis |
WO2016144830A1 (en) | 2015-03-06 | 2016-09-15 | Concert Pharmaceuticals, Inc. | Deuterated emricasan |
EP4272744A3 (en) | 2015-03-11 | 2024-01-24 | Alexza Pharmaceuticals, Inc. | Use of antistatic materials in the airway for thermal aerosol condensation process |
CA2981495C (en) | 2015-03-31 | 2023-09-26 | Vertex Pharmaceuticals (Europe) Limited | Deuterated vx-661 |
EP4186548A1 (en) | 2015-04-02 | 2023-05-31 | Hill-Rom Services PTE. LTD. | Mask leakage detection for a respiratory device |
US10683305B2 (en) | 2015-04-27 | 2020-06-16 | Concert Pharmaceuticals, Inc. | Deuterated OTX-015 |
EP3294298A4 (en) | 2015-05-08 | 2018-10-17 | President and Fellows of Harvard College | Cortistatin analogues, syntheses, and uses thereof |
EP3316883A4 (en) * | 2015-06-30 | 2019-06-12 | University of South Florida | INHIBITORS OF THE FKBP51 PROTEIN FROM A HIGH-BY-STEP MEDICAMENT SCREENING AND METHOD OF USE THEREOF |
EP3316889A4 (en) | 2015-07-01 | 2018-11-14 | President and Fellows of Harvard College | Cortistatin analogues and syntheses and uses thereof |
AU2016287582B2 (en) | 2015-07-02 | 2020-03-12 | Civitas Therapeutics, Inc. | Triptan powders for pulmonary delivery |
CA2994169A1 (en) | 2015-07-30 | 2017-02-02 | Concert Pharmaceuticals, Inc. | Deuterated morphinan compounds for use in treating agitation |
WO2017020005A1 (en) | 2015-07-30 | 2017-02-02 | Concert Pharmaceuticals, Inc. | Morphinan compounds for use in treating agitation |
US11266799B2 (en) | 2015-09-10 | 2022-03-08 | Impel Neuropharma, Inc. | In-line nasal delivery device |
WO2017087795A1 (en) | 2015-11-19 | 2017-05-26 | Concert Pharmaceuticals, Inc. | Deuterated epi-743 |
JP2019501899A (ja) | 2015-12-09 | 2019-01-24 | リサーチ トライアングル インスティテュート | 改良アペリンレセプター(apj)アゴニストおよびその使用 |
CA3007673A1 (en) | 2015-12-22 | 2017-06-29 | Zogenix International Limited | Metabolism resistant fenfluramine analogs and methods of using the same |
EP4293009A3 (en) * | 2015-12-22 | 2024-02-21 | Zogenix International Limited | Fenfluramine compositions and methods of preparing the same |
US10092036B2 (en) * | 2015-12-28 | 2018-10-09 | Rai Strategic Holdings, Inc. | Aerosol delivery device including a housing and a coupler |
EP3399972B1 (en) | 2016-01-06 | 2021-03-31 | Syqe Medical Ltd. | Low dose therapeutic treatment |
CN114847965A (zh) | 2016-02-01 | 2022-08-05 | 英凯达治疗公司 | 电子监测联合吸入药理学疗法管理心律失常 |
US20170216220A1 (en) * | 2016-02-03 | 2017-08-03 | Intelgenx Corp. | Loxapine film oral dosage form |
WO2017147003A1 (en) | 2016-02-26 | 2017-08-31 | Novobiotic Pharmaceuticals, Llc | Novel macrocyclic antibiotics and uses thereof |
KR102539584B1 (ko) | 2016-06-15 | 2023-06-02 | 더 제너럴 하스피탈 코포레이션 | 생물직교 반응을 사용하는 생물학적 물질의 대사적 표지화 및 분자적 향상 |
PT3478664T (pt) | 2016-07-04 | 2020-12-28 | Avanir Pharmaceuticals Inc | Métodos para a síntese de dextrometorfano deuterado |
KR102511953B1 (ko) | 2016-08-01 | 2023-03-20 | 더 브리검 앤드 우먼즈 하스피털, 인크. | 단백질 및 펩티드 전달용 입자 |
US20180055789A1 (en) | 2016-08-24 | 2018-03-01 | Zogenix International Limited | Formulation for inhibiting formation of 5-ht2b agonists and methods of using same |
DE102016221705B4 (de) | 2016-11-07 | 2018-05-17 | Schaeffler Technologies AG & Co. KG | Zahnrad aus einem Zahnradverbund und Verfahren zur Herstellung eines Zahnradverbundes |
US20180185347A1 (en) * | 2016-11-16 | 2018-07-05 | Transition Therapeutics (Ireland 2) Limited | Tetrahydrocyclopenta[b]indole compounds and phosphodiesterase inhibitors for the treatment of the signs and symptoms of bhp |
DK3551189T3 (da) | 2016-12-09 | 2024-01-29 | Alexza Pharmaceuticals Inc | Alprazolam til anvendelse ved behandling af epilepsi |
CA3036382A1 (en) | 2016-12-21 | 2018-06-28 | Research Triangle Institute | Diaryl purine derivatives with improved bioavailability |
HRP20231706T1 (hr) | 2017-02-02 | 2024-03-15 | Otolanum Ag | Intranazalni pripravak koji sadrži betahistin |
JP7152408B2 (ja) | 2017-03-10 | 2022-10-12 | キアペグ ファーマシューティカルズ アクチエボラグ | 遊離可能コンジュゲート |
EP3595653B1 (en) | 2017-03-13 | 2023-03-08 | Beyondspring Pharmaceuticals, Inc. | Compositions of plinabulin and use thereof |
WO2018209107A1 (en) | 2017-05-10 | 2018-11-15 | Incarda Therapeutics, Inc. | Unit doses, aerosols, kits, and methods for treating heart conditions by pulmonary administration |
ES2928723T3 (es) | 2017-05-19 | 2022-11-22 | Superb Wisdom Ltd | Derivados de Resiquimod |
WO2018223065A1 (en) | 2017-06-01 | 2018-12-06 | Xoc Pharmaceuticals, Inc. | Ergoline derivatives for use in medicine |
WO2018232252A1 (en) | 2017-06-15 | 2018-12-20 | Mayo Foundation For Medical Education And Research | Methods to treat gliomas using a stat3 inhibitor |
EP3641756B1 (en) | 2017-06-16 | 2023-08-09 | The General Hospital Corporation | Tricyclic compounds as cyp1 inhibitors |
US9993486B1 (en) | 2017-06-19 | 2018-06-12 | Tlc Therapeutics, Llc | Oral quetiapine suspension formulations with extended shelf life and enhanced bioavailability |
CN109391578B (zh) * | 2017-08-11 | 2022-07-22 | 华为技术有限公司 | 信号发送方法、信号接收方法、终端设备及网络设备 |
US10682317B2 (en) | 2017-09-26 | 2020-06-16 | Zogenix International Limited | Ketogenic diet compatible fenfluramine formulation |
CA3074985A1 (en) | 2017-10-16 | 2019-04-25 | Dana-Farber Cancer Institute, Inc. | Compounds and methods for treating cancer |
CA3081680A1 (en) | 2017-11-21 | 2019-05-31 | Impel Neuropharma, Inc. | Intranasal device with inlet interface |
WO2019104205A1 (en) | 2017-11-21 | 2019-05-31 | Impel Neuropharma, Inc. | Intranasal device with dip tube |
WO2019136308A1 (en) | 2018-01-05 | 2019-07-11 | Impel Neuropharma, Inc. | Intranasal delivery of olanzapine by precision olfactory device |
AU2019205318B2 (en) | 2018-01-05 | 2022-02-03 | Impel Pharmaceuticals Inc. | Intranasal delivery of dihydroergotamine by precision olfactory device |
CA3089864A1 (en) | 2018-01-31 | 2019-08-08 | Mayo Foundation For Medical Education And Research | Methods of treating fibrotic pathologies |
US10744087B2 (en) | 2018-03-22 | 2020-08-18 | Incarda Therapeutics, Inc. | Method to slow ventricular rate |
CA3097335A1 (en) | 2018-05-11 | 2019-11-14 | Zogenix International Limited | Compositions and methods for treating seizure-induced sudden death |
WO2020009560A1 (es) | 2018-07-04 | 2020-01-09 | AMÉZCUA AMÉZCUA, Federico | Combinación farmacéutica sinérgica del enantiómero activo s-ketorolaco y gabapentina para el tratamiento del dolor neuropático |
AU2019299234A1 (en) | 2018-07-05 | 2021-01-14 | Mayo Foundation For Medical Education And Research | PIKfyve inhibitors |
US11517548B2 (en) | 2018-07-19 | 2022-12-06 | Impel Pharmaceuticals Inc. | Respiratory tract delivery of levodopa and DOPA decarboxylase inhibitor for treatment of Parkinson's Disease |
EP3838270A4 (en) | 2018-08-13 | 2022-03-09 | Amézcua Amézcua, Federico | SYNERGISTIC PHARMACEUTICAL COMPOSITION WITH ACECLOFENAC AND BETAMETHASONE FOR THE TREATMENT OF PAIN IN LOCALIZED FORMS OF RHEUMATIC DISEASES |
US11090449B2 (en) | 2018-08-21 | 2021-08-17 | Vivera Pharmaceuticals Inc. | Smart inhaler device with automated dose delivery, measurement, and management |
US11083850B2 (en) | 2018-08-21 | 2021-08-10 | Vivera Pharmaceuticals Inc. | Secure smart dosing system with automated delivery, measurement, and management |
TWI834720B (zh) | 2018-09-12 | 2024-03-11 | 瑞典商奎亞培格製藥公司 | 可釋放glp-1共軛物 |
KR20210109007A (ko) | 2019-01-03 | 2021-09-03 | 임펠 뉴로파마 인코포레이티드 | 비강 약물 전달 장치 |
WO2020142748A1 (en) | 2019-01-03 | 2020-07-09 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Methods and materials for increasing transcription factor eb polypeptide levels |
MX2019000312A (es) | 2019-01-08 | 2019-10-09 | Federico Amezcua Amezcua | Composicion farmaceutica sinergica de aceclofenaco y betametasona para el tratamiento del dolor de afecciones reumaticas o dolor postquirurgico. |
CN109674773A (zh) * | 2019-02-22 | 2019-04-26 | 南京中医药大学 | 一种肺部给药的昔多芬药物微粒及其制备方法与应用 |
CN114025816A (zh) | 2019-05-17 | 2022-02-08 | 英倍尔药业股份有限公司 | 一次性鼻腔给送装置 |
EP4003348B1 (en) | 2019-07-30 | 2024-04-03 | Mayo Foundation for Medical Education and Research | Compounds and methods for treating fibrotic pathologies |
US11020384B2 (en) | 2019-08-01 | 2021-06-01 | Incarda Therapeutics, Inc. | Antiarrhythmic formulation |
US11364225B2 (en) | 2019-08-21 | 2022-06-21 | Bn Intellectual Properties, Inc. | Pharmaceutical formulation for treating symptoms of migraine and cluster headaches, and method of using the same |
WO2021055079A1 (en) | 2019-09-16 | 2021-03-25 | Vapor Cartridge Technology Llc | Drug delivery system with stackable substrates |
US12070554B2 (en) | 2019-11-11 | 2024-08-27 | Hill-Rom Services Pte. Ltd. | Pneumatic connector apparatus and method |
JP7495989B2 (ja) * | 2020-02-14 | 2024-06-05 | テイコク ファーマ ユーエスエー インコーポレーテッド | 局所用ナロキソン組成物およびそれを使用するための方法 |
EP3868364A1 (en) * | 2020-02-24 | 2021-08-25 | GH Research Limited | Aerosol comprising 5-methoxy-n,n-dimethyltryptamine |
US11612574B2 (en) | 2020-07-17 | 2023-03-28 | Zogenix International Limited | Method of treating patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) |
US11071739B1 (en) | 2020-09-29 | 2021-07-27 | Genus Lifesciences Inc. | Oral liquid compositions including chlorpromazine |
US20220117916A1 (en) * | 2020-10-19 | 2022-04-21 | SafeRx Pharmaceuticals, LLC | Combination Products to Mitigate the Risk of Non-Benzodiazepine Benzodiazepine Agonist Adverse Reaction and Overdose |
EP4159192A1 (en) | 2021-09-30 | 2023-04-05 | Biomind Labs Inc | Dimethyltriptamine-based nasal spray for the personalised treatment of neurological and psychiatric disorders |
JPWO2023063381A1 (es) * | 2021-10-14 | 2023-04-20 | ||
IT202100031637A1 (it) | 2021-12-17 | 2023-06-17 | Universita’ Degli Studi Di Parma | Polveri per inalazione e procedimento di produzione |
EP4349175A1 (en) | 2022-10-05 | 2024-04-10 | The Procter & Gamble Company | Antimicrobial composition comprising a modified alkyl glycoside and an organic acid |
Family Cites Families (273)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US113557A (en) * | 1871-04-11 | Improvement in metal screws and nuts | ||
US32638A (en) * | 1861-06-25 | Boot-heel | ||
US30285A (en) * | 1860-10-09 | Fruit-drier | ||
US58009A (en) * | 1866-09-11 | Improved condenser | ||
GB502761A (en) | 1938-01-29 | 1939-03-24 | Christopher Engelbreth | Improvements in and relating to hand inhalation apparatus |
US2902484A (en) | 1954-04-27 | 1959-09-01 | Rhone Poulenc Sa | Phenthiazine derivatives and processes for their preparation |
US3474101A (en) | 1960-09-05 | 1969-10-21 | Reckitt & Sons Ltd | Thebaine and oripavine derivatives |
NL135583C (es) | 1961-10-10 | |||
GB972363A (en) | 1962-08-18 | 1964-10-14 | Rambold Adolf | Wrapper band for teabag or the like |
US3169095A (en) | 1962-10-30 | 1965-02-09 | Rexall Drug Chemical | Self-propelling powder-dispensing compositions |
NL289785A (es) | 1962-11-29 | |||
GB1063512A (en) | 1962-11-30 | 1967-03-30 | Benger Lab Ltd | Aerosols |
US3456247A (en) * | 1966-01-14 | 1969-07-15 | Ibm | Coupled film storage device |
IL26896A (en) | 1966-01-19 | 1970-11-30 | Endo Lab | 14 - Hydroxynormorphinins and 14 - Hydroxynormorphinones |
US3987052A (en) | 1969-03-17 | 1976-10-19 | The Upjohn Company | 6-Phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepines |
USRE30285E (en) | 1972-05-22 | 1980-05-27 | Spraying devices, in particular nebulizing devices | |
US3949743A (en) * | 1973-03-19 | 1976-04-13 | Schick Incorporated | Medicated vapor production method and apparatus |
US3982095A (en) | 1973-10-04 | 1976-09-21 | Searle Cardio-Pulmonary Systems Inc. | Respiratory humidifier |
US3894040A (en) | 1974-09-16 | 1975-07-08 | American Home Prod | 2,5,6,7-Tetrahydro-3H-imidazo(1,2-D)(1,4)benzodiazepine-5,6-dicarboxylic acid esters |
US4121583A (en) | 1976-07-13 | 1978-10-24 | Wen Yuan Chen | Method and apparatus for alleviating asthma attacks |
US4141369A (en) | 1977-01-24 | 1979-02-27 | Burruss Robert P | Noncombustion system for the utilization of tobacco and other smoking materials |
SE7812207L (sv) | 1977-12-01 | 1979-06-02 | Welsh Nat School Med | Apparat, forfarande och framstellda produkter for anvendning vid administration av antihistaminer |
US4183912A (en) | 1978-01-16 | 1980-01-15 | American Home Products Corporation | Inhalation therapy for relieving bronchial spasm using quaternary salts of promethazine |
US4484451A (en) * | 1978-09-05 | 1984-11-27 | United Air Specialists, Inc. | Two-stage gas condenser with feedback cooling |
IL59407A (en) | 1979-03-06 | 1983-12-30 | Sanofi Sa | Di-n-propylacetic acid diesters of glycerol,their preparation and pharmaceutical compositions containing them |
US4654370A (en) | 1979-03-12 | 1987-03-31 | Abbott Laboratories | Glyceryl valproates |
US4229447A (en) | 1979-06-04 | 1980-10-21 | American Home Products Corporation | Intraoral methods of using benzodiazepines |
EP0039369B1 (en) | 1980-05-02 | 1983-06-15 | Schering Corporation | Beclomethasone ester solvates, process for their preparation, and preparation of a formulation |
US4303083A (en) | 1980-10-10 | 1981-12-01 | Burruss Jr Robert P | Device for evaporation and inhalation of volatile compounds and medications |
US4376767A (en) | 1981-01-02 | 1983-03-15 | Merck & Co., Inc. | Pyridylmethyl esters of selected bio-affecting carboxylic acids |
DE3116951C2 (de) | 1981-04-29 | 1984-12-20 | Drägerwerk AG, 2400 Lübeck | Vorrichtung zur Beimischung flüssiger Narkosemittel in das dem Patienten zuzuführende Atemgas |
DE3224849A1 (de) | 1982-07-02 | 1984-01-05 | Plantorgan Werk Heinrich G.E. Christensen, KG, 2903 Bad Zwischenahn | Dampfinhaliergeraet |
US4508726A (en) | 1982-09-16 | 1985-04-02 | The Upjohn Company | Treatment of panic disorders with alprazolam |
US4693868A (en) | 1982-09-30 | 1987-09-15 | Dainihon Jochugiku Co., Ltd. | Thermal fumigator for drugs |
US4474191A (en) | 1982-09-30 | 1984-10-02 | Steiner Pierre G | Tar-free smoking devices |
US4753758A (en) | 1983-05-19 | 1988-06-28 | Intertech Resources Inc. | Respiratory humidifier |
DE3326089A1 (de) | 1983-07-20 | 1985-02-07 | Gödecke AG, 1000 Berlin | Zur inhalation bestimmte darreichungsform von calcium-antagonisten |
AU591451B2 (en) | 1983-08-01 | 1989-12-07 | Mclean Hospital Corporation, The | Gamma amino butyric acid esters |
US4588721A (en) | 1983-09-12 | 1986-05-13 | The Upjohn Company | Treatment of negative symptoms of schizophrenia |
US4566552A (en) * | 1983-11-16 | 1986-01-28 | International Harvester Company | Hood tilt retardation system |
US4683231A (en) | 1984-03-02 | 1987-07-28 | Research Foundation For Mental Hygiene, Inc. | Method of preventing withdrawal symptoms associated with the cessation or reduction of tobacco smoking |
US5020548A (en) | 1985-08-26 | 1991-06-04 | R. J. Reynolds Tobacco Company | Smoking article with improved fuel element |
US5042509A (en) | 1984-09-14 | 1991-08-27 | R. J. Reynolds Tobacco Company | Method for making aerosol generating cartridge |
US4793365A (en) | 1984-09-14 | 1988-12-27 | R. J. Reynolds Tobacco Company | Smoking article |
US5067499A (en) | 1984-09-14 | 1991-11-26 | R. J. Reynolds Tobacco Company | Smoking article |
US4854331A (en) | 1984-09-14 | 1989-08-08 | R. J. Reynolds Tobacco Company | Smoking article |
CN1018607B (zh) | 1984-12-21 | 1992-10-14 | 美国耳·杰·瑞诺兹烟草公司 | 吸烟制品 |
US4928714A (en) | 1985-04-15 | 1990-05-29 | R. J. Reynolds Tobacco Company | Smoking article with embedded substrate |
DE3686025T2 (de) | 1985-05-22 | 1993-01-07 | Liposome Technology Inc | Verfahren und system zum einatmen von liposomen. |
US4989619A (en) | 1985-08-26 | 1991-02-05 | R. J. Reynolds Tobacco Company | Smoking article with improved fuel element |
US5060666A (en) | 1985-10-28 | 1991-10-29 | R. J. Reynolds Tobacco Company | Smoking article with tobacco jacket |
US4756318A (en) | 1985-10-28 | 1988-07-12 | R. J. Reynolds Tobacco Company | Smoking article with tobacco jacket |
US5033483A (en) | 1985-10-28 | 1991-07-23 | R. J. Reynolds Tobacco Company | Smoking article with tobacco jacket |
JPS62204756A (ja) * | 1986-03-04 | 1987-09-09 | 大研医工株式会社 | 薬剤揮散方法および装置 |
WO1987005210A1 (en) | 1986-03-10 | 1987-09-11 | Kurt Burghart | Pharmaceutical preparation and process for preparing the same |
US4708151A (en) | 1986-03-14 | 1987-11-24 | R. J. Reynolds Tobacco Company | Pipe with replaceable cartridge |
US4771795A (en) | 1986-05-15 | 1988-09-20 | R. J. Reynolds Tobacco Company | Smoking article with dual burn rate fuel element |
US4917120A (en) | 1986-05-21 | 1990-04-17 | Advanced Tobacco Products, Inc. | Nicotine impact modification |
US4735217A (en) * | 1986-08-21 | 1988-04-05 | The Procter & Gamble Company | Dosing device to provide vaporized medicament to the lungs as a fine aerosol |
US4858630A (en) | 1986-12-08 | 1989-08-22 | R. J. Reynolds Tobacco Company | Smoking article with improved aerosol forming substrate |
US4734560A (en) | 1987-01-20 | 1988-03-29 | Medical Enterprises, Ltd. | Vaporizing unit |
US4819665A (en) | 1987-01-23 | 1989-04-11 | R. J. Reynolds Tobacco Company | Aerosol delivery article |
US4924883A (en) * | 1987-03-06 | 1990-05-15 | R. J. Reynolds Tobacco Company | Smoking article |
US5017575A (en) | 1987-06-09 | 1991-05-21 | Golwyn Daniel H | Treatment of immunologically based disorders, specifically Crohn's disease |
GB8713645D0 (en) | 1987-06-11 | 1987-07-15 | Imp Tobacco Ltd | Smoking device |
US5019122A (en) | 1987-08-21 | 1991-05-28 | R. J. Reynolds Tobacco Company | Smoking article with an enclosed heat conductive capsule containing an aerosol forming substance |
US4906417A (en) | 1988-02-08 | 1990-03-06 | Associated Mills Inc. | Humidifier |
US4853517A (en) | 1988-03-28 | 1989-08-01 | John G. Bowen | Vaporizing unit |
US4906119A (en) * | 1988-04-14 | 1990-03-06 | Lloyd Hartford | Handwriting stabilizer |
DE3815221C2 (de) | 1988-05-04 | 1995-06-29 | Gradinger F Hermes Pharma | Verwendung einer Retinol- und/oder Retinsäureester enthaltenden pharmazeutischen Zubereitung zur Inhalation zur Einwirkung auf die Schleimhäute des Tracheo-Bronchialtraktes einschließlich der Lungenalveolen |
US4881556A (en) | 1988-06-06 | 1989-11-21 | R. J. Reynolds Tobacco Company | Low CO smoking article |
US5345951A (en) * | 1988-07-22 | 1994-09-13 | Philip Morris Incorporated | Smoking article |
EP0358114A3 (en) | 1988-09-08 | 1990-11-14 | R.J. Reynolds Tobacco Company | Aerosol delivery articles utilizing electrical energy |
US4947874A (en) | 1988-09-08 | 1990-08-14 | R. J. Reynolds Tobacco Company | Smoking articles utilizing electrical energy |
US4922901A (en) | 1988-09-08 | 1990-05-08 | R. J. Reynolds Tobacco Company | Drug delivery articles utilizing electrical energy |
US4947875A (en) | 1988-09-08 | 1990-08-14 | R. J. Reynolds Tobacco Company | Flavor delivery articles utilizing electrical energy |
USRE36744E (en) | 1988-09-16 | 2000-06-20 | Ribogene, Inc. | Nasal administration of benzodiazepine hypnotics |
US4950664A (en) | 1988-09-16 | 1990-08-21 | Rugby-Darby Group Companies, Inc. | Nasal administration of benzodiazepine hypnotics |
US4963289A (en) | 1988-09-19 | 1990-10-16 | The United States Of America As Represented By The United States Department Of Energy | Method for producing monodisperse aerosols |
US5511726A (en) * | 1988-09-23 | 1996-04-30 | Battelle Memorial Institute | Nebulizer device |
US4917119A (en) | 1988-11-30 | 1990-04-17 | R. J. Reynolds Tobacco Company | Drug delivery article |
US4906476A (en) | 1988-12-14 | 1990-03-06 | Liposome Technology, Inc. | Novel liposome composition for sustained release of steroidal drugs in lungs |
GB8900267D0 (en) | 1989-01-06 | 1989-03-08 | Riker Laboratories Inc | Narcotic analgesic formulations and apparatus containing same |
DE3908161A1 (de) * | 1989-03-13 | 1990-09-27 | Bat Cigarettenfab Gmbh | Rauchbarer artikel |
JP3062760B2 (ja) * | 1989-03-14 | 2000-07-12 | コニカ株式会社 | 複合レンズ |
DE69034007T2 (de) | 1989-04-28 | 2003-05-08 | Riker Laboratories Inc., Northridge | Inhalationsvorrichtung für Trockenpulver |
KR920700648A (ko) | 1989-05-05 | 1992-08-10 | 오닐 크리스토퍼 | 가임성 향상 |
ATE93596T1 (de) * | 1989-05-17 | 1993-09-15 | Leifeld Gmbh & Co | Verfahren zur herstellung einer riemenscheibe. |
US4941483A (en) | 1989-09-18 | 1990-07-17 | R. J. Reynolds Tobacco Company | Aerosol delivery article |
US6048857A (en) | 1989-10-17 | 2000-04-11 | Ellinwood, Jr.; Everett H. | Dosing method of administering medicaments via inhalation administration |
US6313176B1 (en) | 1989-10-17 | 2001-11-06 | Everett J. Ellinwood, Jr. | Dosing method of administering deprenyl via intraoral administration or inhalation administration |
US5707644A (en) | 1989-11-04 | 1998-01-13 | Danbiosyst Uk Limited | Small particle compositions for intranasal drug delivery |
US5144962A (en) | 1989-12-01 | 1992-09-08 | Philip Morris Incorporated | Flavor-delivery article |
US5224498A (en) | 1989-12-01 | 1993-07-06 | Philip Morris Incorporated | Electrically-powered heating element |
US5060671A (en) * | 1989-12-01 | 1991-10-29 | Philip Morris Incorporated | Flavor generating article |
AU6909091A (en) | 1989-12-05 | 1991-06-26 | Ramsey Foundation | Neurologic agents for nasal administration to the brain |
GB2239807A (en) * | 1990-01-09 | 1991-07-17 | Boc Group Plc | Anaesthetic vaporiser |
US5376386A (en) * | 1990-01-24 | 1994-12-27 | British Technology Group Limited | Aerosol carriers |
US5099861A (en) | 1990-02-27 | 1992-03-31 | R. J. Reynolds Tobacco Company | Aerosol delivery article |
US5366770A (en) | 1990-04-17 | 1994-11-22 | Xingwu Wang | Aerosol-plasma deposition of films for electronic cells |
US5455043A (en) | 1990-06-13 | 1995-10-03 | Fischel-Ghodsian; Fariba | Device for controlled release of vaporous medications through nasal route |
US5126123A (en) | 1990-06-28 | 1992-06-30 | Glaxo, Inc. | Aerosol drug formulations |
DE69110785T3 (de) | 1990-08-02 | 2002-05-23 | The Boc Group Plc, Windlesham | Narkosemittelverdampfer. |
US5292499A (en) | 1990-09-11 | 1994-03-08 | University Of Wales College Of Cardiff | Method of preparing medical aerosol formulations including drug dissolved in reverse micelles |
US5166202A (en) | 1990-09-19 | 1992-11-24 | Trustees Of The University Of Pennsylvania | Method for the treatment of panic disorder |
US5175152A (en) | 1990-09-28 | 1992-12-29 | Singh Nikhilesh N | Composition containing ephedrine base and alkyl salicylate for the delivery of ephedrine base in vapor form |
US5343226A (en) * | 1990-09-28 | 1994-08-30 | Dataproducts Corporation | Ink jet ink supply apparatus |
DE69229070T2 (de) | 1991-02-09 | 1999-11-18 | B.S.D. Bio Science Development Snc Di Omini C. & Zuccari G., Bussero | Antireaktive antiasthmatische Wirkung von Acetylsalicylsäure durch Inhalation |
US5993805A (en) | 1991-04-10 | 1999-11-30 | Quadrant Healthcare (Uk) Limited | Spray-dried microparticles and their use as therapeutic vehicles |
US5457100A (en) | 1991-12-02 | 1995-10-10 | Daniel; David G. | Method for treatment of recurrent paroxysmal neuropsychiatric |
US5639441A (en) | 1992-03-06 | 1997-06-17 | Board Of Regents Of University Of Colorado | Methods for fine particle formation |
CA2115444C (en) | 1992-06-12 | 2000-10-03 | Yuji Makino | Preparation for intratracheobronchial administration |
US5622944A (en) | 1992-06-12 | 1997-04-22 | Affymax Technologies N.V. | Testosterone prodrugs for improved drug delivery |
US5607691A (en) | 1992-06-12 | 1997-03-04 | Affymax Technologies N.V. | Compositions and methods for enhanced drug delivery |
US5284133A (en) * | 1992-07-23 | 1994-02-08 | Armstrong Pharmaceuticals, Inc. | Inhalation device with a dose-timer, an actuator mechanism, and patient compliance monitoring means |
WO1994009842A1 (en) * | 1992-10-28 | 1994-05-11 | Rosen Charles A | Method and devices for delivering drugs by inhalation |
US5558085A (en) | 1993-01-29 | 1996-09-24 | Aradigm Corporation | Intrapulmonary delivery of peptide drugs |
US5694919A (en) | 1993-01-29 | 1997-12-09 | Aradigm Corporation | Lockout device for controlled release of drug from patient-activated dispenser |
US5507277A (en) | 1993-01-29 | 1996-04-16 | Aradigm Corporation | Lockout device for controlled release of drug from patient-activateddispenser |
US5915378A (en) | 1993-01-29 | 1999-06-29 | Aradigm Corporation | Creating an aerosolized formulation of insulin |
US5672581A (en) | 1993-01-29 | 1997-09-30 | Aradigm Corporation | Method of administration of insulin |
US5934272A (en) | 1993-01-29 | 1999-08-10 | Aradigm Corporation | Device and method of creating aerosolized mist of respiratory drug |
US5724957A (en) | 1993-01-29 | 1998-03-10 | Aradigm Corporation | Intrapulmonary delivery of narcotics |
US5357257A (en) * | 1993-04-05 | 1994-10-18 | General Electric Company | Apparatus and method for equalizing channels in a multi-channel communication system |
US5497763A (en) | 1993-05-21 | 1996-03-12 | Aradigm Corporation | Disposable package for intrapulmonary delivery of aerosolized formulations |
US5666977A (en) | 1993-06-10 | 1997-09-16 | Philip Morris Incorporated | Electrical smoking article using liquid tobacco flavor medium delivery system |
JP3553599B2 (ja) * | 1993-06-29 | 2004-08-11 | インジェット ディジタル エアロソルズ リミテッド | ディスペンサー |
US5388574A (en) | 1993-07-29 | 1995-02-14 | Ingebrethsen; Bradley J. | Aerosol delivery article |
DE4328243C1 (de) | 1993-08-19 | 1995-03-09 | Sven Mielordt | Rauch- oder Inhalationsvorrichtung |
US5456247A (en) | 1993-08-26 | 1995-10-10 | Iowa State University Research Foundation, Inc. | Method for delivering drugs soluble in a vaporization vehicle |
FI98270C (fi) * | 1993-11-29 | 1997-05-26 | Instrumentarium Oy | Menetelmä ja sovitelma anesteetin höyrystämisen yhteydessä |
US5543434A (en) | 1994-02-25 | 1996-08-06 | Weg; Stuart L. | Nasal administration of ketamine to manage pain |
US5451408A (en) | 1994-03-23 | 1995-09-19 | Liposome Pain Management, Ltd. | Pain management with liposome-encapsulated analgesic drugs |
US6102036A (en) | 1994-04-12 | 2000-08-15 | Smoke-Stop | Breath activated inhaler |
EP0759744B1 (en) | 1994-05-13 | 2001-10-17 | Aradigm Corporation | Narcotic containing aerosol formulation |
US5522385A (en) | 1994-09-27 | 1996-06-04 | Aradigm Corporation | Dynamic particle size control for aerosolized drug delivery |
ES2171196T3 (es) | 1994-10-14 | 2002-09-01 | Glaxosmithkline Spa | Uso de antagonistas del receptor cck-b para el tratamiento de trastornos del sueño. |
JP3748890B2 (ja) | 1994-10-28 | 2006-02-22 | アラダイム コーポレーション | 呼吸器薬物のエアロゾル化噴霧に使用するための使い捨て容器、使い捨てパッケージ、薬物輸送装置、及びエアロゾルを生成する方法 |
US5767117A (en) | 1994-11-18 | 1998-06-16 | The General Hospital Corporation | Method for treating vascular headaches |
EP0817655B1 (en) | 1995-03-31 | 2004-05-19 | Aradigm Corporation | Intrapulmonary delivery of hematopoietic drug |
US5758637A (en) | 1995-08-31 | 1998-06-02 | Aerogen, Inc. | Liquid dispensing apparatus and methods |
US5612053A (en) | 1995-04-07 | 1997-03-18 | Edward Mendell Co., Inc. | Controlled release insufflation carrier for medicaments |
US6258341B1 (en) | 1995-04-14 | 2001-07-10 | Inhale Therapeutic Systems, Inc. | Stable glassy state powder formulations |
DE19519056A1 (de) | 1995-05-24 | 1997-01-16 | Klinge Co Chem Pharm Fab | Verwendung von Antidepressiva zur Behandlung von Asthma und/oder Atemwegserkrankungen mittels inhalatorischer Applikation |
US5874481A (en) | 1995-06-07 | 1999-02-23 | Alliance Pharmaceutical Corp. | Fluorochemical solutions for the delivery of lipophilic pharmaceutical agents |
US6245347B1 (en) | 1995-07-28 | 2001-06-12 | Zars, Inc. | Methods and apparatus for improved administration of pharmaceutically active compounds |
JPH0943487A (ja) | 1995-08-01 | 1997-02-14 | Fuji Photo Film Co Ltd | ズームレンズ |
US5649554A (en) | 1995-10-16 | 1997-07-22 | Philip Morris Incorporated | Electrical lighter with a rotatable tobacco supply |
AU7669496A (en) | 1995-11-03 | 1997-05-22 | University Of Kentucky | Method for the intranasal administration of l-dopa prodrugs |
US6017963A (en) | 1995-11-14 | 2000-01-25 | Euro-Celtique, S.A. | Formulation for intranasal administration |
US5564442A (en) | 1995-11-22 | 1996-10-15 | Angus Collingwood MacDonald | Battery powered nicotine vaporizer |
US6041777A (en) * | 1995-12-01 | 2000-03-28 | Alliance Pharmaceutical Corp. | Methods and apparatus for closed-circuit ventilation therapy |
WO1997021426A1 (fr) | 1995-12-14 | 1997-06-19 | Taisho Pharmaceutical Co., Ltd. | Preparation aerosol |
SE9504580L (sv) * | 1995-12-21 | 1997-06-22 | Siemens Elema Ab | Förfarande vid förgasning av en narkosvätska och en förgasare |
EP0955885A1 (en) | 1996-02-05 | 1999-11-17 | Aradigm Corporation | Ventilation imaging using a fine particle aerosol generator |
AUPN814496A0 (en) | 1996-02-19 | 1996-03-14 | Monash University | Dermal penetration enhancer |
US5927124A (en) * | 1996-03-05 | 1999-07-27 | Adaptive Motion Control Systems, Inc. | Apparatus for bending and cutting tubing, and method of using same |
GB9606188D0 (en) * | 1996-03-23 | 1996-05-29 | Danbiosyst Uk | Pollysaccharide microspheres for the pulmonary delivery of drugs |
GB9606677D0 (en) | 1996-03-29 | 1996-06-05 | Glaxo Wellcome Inc | Process and device |
NZ332669A (en) * | 1996-04-29 | 1999-02-25 | Dura Pharma Inc | A dry power inhalation system which is flow rate independent |
US5743251A (en) | 1996-05-15 | 1998-04-28 | Philip Morris Incorporated | Aerosol and a method and apparatus for generating an aerosol |
US5874064A (en) | 1996-05-24 | 1999-02-23 | Massachusetts Institute Of Technology | Aerodynamically light particles for pulmonary drug delivery |
US5855913A (en) * | 1997-01-16 | 1999-01-05 | Massachusetts Instite Of Technology | Particles incorporating surfactants for pulmonary drug delivery |
GB9613015D0 (en) | 1996-06-21 | 1996-08-28 | Reckitt & Colman Inc | Device |
BR9710289A (pt) | 1996-07-11 | 1999-08-17 | Farmarc Nederland Bv | Composi-Æo farmac-utica contendo sal cido de adi-Æo de medicamento b sico |
US6131570A (en) | 1998-06-30 | 2000-10-17 | Aradigm Corporation | Temperature controlling device for aerosol drug delivery |
US6694975B2 (en) * | 1996-11-21 | 2004-02-24 | Aradigm Corporation | Temperature controlling device for aerosol drug delivery |
US5906202A (en) | 1996-11-21 | 1999-05-25 | Aradigm Corporation | Device and method for directing aerosolized mist to a specific area of the respiratory tract |
WO1998031346A1 (en) | 1997-01-16 | 1998-07-23 | Massachusetts Institute Of Technology | Preparation of particles for inhalation |
CA2280099C (en) | 1997-02-05 | 2005-12-27 | Jago Pharma Ag | Medical aerosol formulations |
US5829435A (en) | 1997-02-24 | 1998-11-03 | Aradigm Corporation | Prefilter for prevention of clogging of a nozzle in the generation of an aerosol and prevention of administration of undesirable particles |
US5837713A (en) | 1997-02-26 | 1998-11-17 | Mayo Foundation For Medical Education And Research | Treatment of eosinophil-associated pathologies by administration of topical anesthetics and glucocorticoids |
KR100289448B1 (ko) | 1997-07-23 | 2001-05-02 | 미즈노 마사루 | 향미발생장치 |
US5874841A (en) * | 1997-07-28 | 1999-02-23 | Philips Electronics North America Corporation | Sample-and-hold circuit for a switched-mode power supply |
US6090212A (en) | 1997-08-15 | 2000-07-18 | Micro C Technologies, Inc. | Substrate platform for a semiconductor substrate during rapid high temperature processing and method of supporting a substrate |
SK285068B6 (sk) | 1997-09-29 | 2006-05-04 | Nektar Therapeutics | Práškový prostriedok, mikrosféry, spôsob tvorby časticového prostriedku obsahujúceho perforované mikroštruktúry prostredníctvom sušenia striekaním a spôsob tvorby prášku obsahujúceho perforované mikroštruktúry prostredníctvom sušenia striekaním |
US6403597B1 (en) * | 1997-10-28 | 2002-06-11 | Vivus, Inc. | Administration of phosphodiesterase inhibitors for the treatment of premature ejaculation |
US5915841A (en) * | 1998-01-05 | 1999-06-29 | Capstone Turbine Corporation | Compliant foil fluid film radial bearing |
US20020006181A1 (en) | 1998-01-23 | 2002-01-17 | Mackenzie Innes K. | Method and device for estimating bone mineral content of the calcaneus |
US6158431A (en) * | 1998-02-13 | 2000-12-12 | Tsi Incorporated | Portable systems and methods for delivery of therapeutic material to the pulmonary system |
WO1999044594A1 (fr) | 1998-03-05 | 1999-09-10 | Nippon Shinyaku Co., Ltd. | Emulsions huileuses destinees a etre administrees par inhalation |
AU765603C (en) * | 1998-04-14 | 2004-08-05 | General Hospital Corporation, The | Methods for treating neuropsychiatric disorders |
AU4680699A (en) | 1998-06-12 | 1999-12-30 | Aradigm Corporation | Methods of delivering aerosolized polynucleotides to the respiratory tract |
US6095153A (en) | 1998-06-19 | 2000-08-01 | Kessler; Stephen B. | Vaporization of volatile materials |
TWI223598B (en) | 1998-06-22 | 2004-11-11 | Pfizer Ireland Pharmaceuticals | An intranasal pharmaceutical composition for the treatment of male erectile dysfunction or female sexual disorders, an intranasal delivery system or device and sildenafil mesylate |
US6241969B1 (en) * | 1998-06-26 | 2001-06-05 | Elan Corporation Plc | Aqueous compositions containing corticosteroids for nasal and pulmonary delivery |
WO2000000215A1 (en) | 1998-06-29 | 2000-01-06 | Inhale Therapeutic Systems, Inc. | Particulate delivery systems and methods of use |
GB9814172D0 (en) | 1998-06-30 | 1998-08-26 | Andaris Ltd | Formulation for inhalation |
MA25590A1 (fr) * | 1998-09-14 | 2002-12-31 | Inhale Therapeutic Syst | Agent actif de delivraison de poudre seche |
US6234167B1 (en) | 1998-10-14 | 2001-05-22 | Chrysalis Technologies, Incorporated | Aerosol generator and methods of making and using an aerosol generator |
US6509005B1 (en) | 1998-10-27 | 2003-01-21 | Virginia Commonwealth University | Δ9 Tetrahydrocannabinol (Δ9 THC) solution metered dose inhaler |
US6255334B1 (en) * | 1998-10-30 | 2001-07-03 | Pfizer Inc | 5HT 1 receptor agonists and metoclopramide for the treatment of migraine |
US7521068B2 (en) | 1998-11-12 | 2009-04-21 | Elan Pharma International Ltd. | Dry powder aerosols of nanoparticulate drugs |
NZ511568A (en) | 1998-11-12 | 2003-08-29 | Frank G | An inhalation system using lipids for the delivery of bioactive compounds |
EP1283036B2 (de) | 1998-11-13 | 2020-01-01 | Jagotec AG | Multidosis-Trockenpulverinhalator mit Pulverreservoir |
US6070575A (en) | 1998-11-16 | 2000-06-06 | Aradigm Corporation | Aerosol-forming porous membrane with certain pore structure |
DK1137398T3 (da) | 1998-12-11 | 2004-02-02 | Pharmachemie Bv | Farmaceutisk præparat til inhalation af et opioid |
US6376550B1 (en) | 1999-02-09 | 2002-04-23 | Asta Medica Ag | Pharmaceutical compositions containing tramadol for migraine |
AU2879100A (en) | 1999-02-12 | 2000-08-29 | Miles A. Libbey Iii | Formulation and system for intra-oral delivery of pharmaceutical agents |
US6591839B2 (en) * | 1999-02-17 | 2003-07-15 | Dieter Meyer | Filter material for reducing harmful substances in tobacco smoke |
US6294192B1 (en) * | 1999-02-26 | 2001-09-25 | Lipocine, Inc. | Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents |
CA2370302A1 (en) | 1999-04-27 | 2000-11-02 | Benjamin Lee Hughes | Insulin crystals for pulmonary administration |
DE60013425T2 (de) | 1999-05-03 | 2005-09-08 | Battelle Memorial Institute, Columbus | Arzneizusammensetzungen zur aerosolbildung und zu inhalationszwecken |
US6428769B1 (en) | 1999-05-04 | 2002-08-06 | Aradigm Corporation | Acute testosterone administration |
GB9912356D0 (en) * | 1999-05-26 | 1999-07-28 | Btg Int Ltd | Generation of microfoam |
KR100752000B1 (ko) | 1999-05-27 | 2007-08-28 | 아쿠스피어 인코포레이티드. | 다공성 약물 매트릭스의 제조방법 |
ES2424713T4 (es) | 1999-06-11 | 2014-01-23 | Aradigm Corporation | Método para producir un aerosol |
US20020061281A1 (en) | 1999-07-06 | 2002-05-23 | Osbakken Robert S. | Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis |
JP4999245B2 (ja) | 1999-07-16 | 2012-08-15 | アラディグム コーポレイション | 禁煙を達成するためのシステム |
CA2380373A1 (en) * | 1999-08-13 | 2001-02-22 | Seth Lederman | Cyclobenzaprine for treating generalized anxiety disorder and compositions thereof |
WO2001013957A2 (en) | 1999-08-24 | 2001-03-01 | Cellgate, Inc. | Enhancing drug delivery across and into epithelial tissues using oligo arginine moieties |
CA2383794A1 (en) | 1999-09-07 | 2001-03-15 | Conjuchem Inc. | Methods and compositions containing succinimide or maleimide derivatives of antineoplastic agents |
EA200200424A1 (ru) | 1999-09-30 | 2002-12-26 | Ньюроджен Корпорейшн | Некоторые гетероциклы, замещенные алкилендиамином |
WO2001028354A1 (fr) * | 1999-10-19 | 2001-04-26 | Agromedic Co., Ltd. | Procede d'alimentation de truies reproductrices et aliments pour truies reproductrices |
NZ518401A (en) | 1999-10-29 | 2004-01-30 | Nektar Therapeutics | Dry powder compositions having improved dispersivity |
WO2001041732A1 (en) | 1999-12-06 | 2001-06-14 | Gore Stanley L | Compositions and methods for intranasal delivery of active agents to the brain |
US6853310B2 (en) * | 1999-12-29 | 2005-02-08 | Ge Medical Systems Information Technologies, Inc. | Tri-mode medical telemetry antenna system |
CN100341483C (zh) * | 2000-02-28 | 2007-10-10 | 维克丘拉有限公司 | 口服药物输递中或涉及口服药物输递的改进 |
US6506765B2 (en) * | 2000-04-07 | 2003-01-14 | Tap Pharmaceutical Products, Inc. | Apomorphine derivatives and methods for their use |
US6632047B2 (en) | 2000-04-14 | 2003-10-14 | Board Of Regents, The University Of Texas System | Heater element for use in an in situ thermal desorption soil remediation system |
MY136453A (en) * | 2000-04-27 | 2008-10-31 | Philip Morris Usa Inc | "improved method and apparatus for generating an aerosol" |
AU2001264817A1 (en) * | 2000-05-23 | 2001-12-17 | Exhale Therapeutics, Inc. | Method for treating respiratory disorders associated with pulmonary elastic fiber injury comprising the use of clycosaminoglycans |
AU2001225664A1 (en) | 2000-06-15 | 2001-12-24 | Respiratorius Ab | 5-ht3 receptor antagonists for treatment of disorders involving airway constriction |
GB0015981D0 (en) | 2000-06-29 | 2000-08-23 | Glaxo Group Ltd | Novel process for preparing crystalline particles |
FR2812545B1 (fr) | 2000-08-03 | 2003-03-28 | Air Liquide Sante Int | Aerosol medicamenteux inhalable dans le traitement ou la prevention de la douceur |
US6514482B1 (en) | 2000-09-19 | 2003-02-04 | Advanced Inhalation Research, Inc. | Pulmonary delivery in treating disorders of the central nervous system |
US6613308B2 (en) | 2000-09-19 | 2003-09-02 | Advanced Inhalation Research, Inc. | Pulmonary delivery in treating disorders of the central nervous system |
US20020117175A1 (en) | 2000-10-27 | 2002-08-29 | Kottayil S. George | Thermal vaporizing device for drug delivery |
EP1383376A4 (en) * | 2001-03-19 | 2006-03-08 | Praecis Pharm Inc | PHARMACEUTICAL FORMULATIONS WITH PROLONGED RELEASE |
US20030004142A1 (en) * | 2001-04-18 | 2003-01-02 | Prior Christopher P. | Use of NSAIDs for prevention and treatment of cellular abnormalities of the lung or bronchial pathway |
US7766013B2 (en) * | 2001-06-05 | 2010-08-03 | Alexza Pharmaceuticals, Inc. | Aerosol generating method and device |
US20030118512A1 (en) * | 2001-10-30 | 2003-06-26 | Shen William W. | Volatilization of a drug from an inclusion complex |
US7090830B2 (en) * | 2001-05-24 | 2006-08-15 | Alexza Pharmaceuticals, Inc. | Drug condensation aerosols and kits |
EP1392260A2 (en) | 2001-05-24 | 2004-03-03 | Alexza Molecular Delivery Corporation | Delivery of benzodiazepines through an inhalation route |
US7645442B2 (en) * | 2001-05-24 | 2010-01-12 | Alexza Pharmaceuticals, Inc. | Rapid-heating drug delivery article and method of use |
US6737043B2 (en) * | 2001-05-24 | 2004-05-18 | Alexza Molecula Delivery Corporation | Delivery of alprazolam, estazolam, midazolam or triazolam through an inhalation route |
EP1392262A1 (en) * | 2001-05-24 | 2004-03-03 | Alexza Molecular Delivery Corporation | Delivery of drug esters through an inhalation route |
US20070122353A1 (en) | 2001-05-24 | 2007-05-31 | Hale Ron L | Drug condensation aerosols and kits |
US7498019B2 (en) * | 2001-05-24 | 2009-03-03 | Alexza Pharmaceuticals, Inc. | Delivery of compounds for the treatment of headache through an inhalation route |
US6805853B2 (en) * | 2001-11-09 | 2004-10-19 | Alexza Molecular Delivery Corporation | Delivery of diazepam through an inhalation route |
US20030138508A1 (en) * | 2001-12-18 | 2003-07-24 | Novack Gary D. | Method for administering an analgesic |
US7458374B2 (en) * | 2002-05-13 | 2008-12-02 | Alexza Pharmaceuticals, Inc. | Method and apparatus for vaporizing a compound |
WO2002094242A1 (en) * | 2001-05-24 | 2002-11-28 | Alexza Molecular Delivery Corporation | Delivery of rizatriptan or zolmitriptan through an inhalation route |
US7078016B2 (en) * | 2001-11-21 | 2006-07-18 | Alexza Pharmaceuticals, Inc. | Delivery of caffeine through an inhalation route |
US7585493B2 (en) * | 2001-05-24 | 2009-09-08 | Alexza Pharmaceuticals, Inc. | Thin-film drug delivery article and method of use |
US20080038363A1 (en) * | 2001-05-24 | 2008-02-14 | Zaffaroni Alejandro C | Aerosol delivery system and uses thereof |
EP1455875A2 (en) * | 2001-11-21 | 2004-09-15 | Alexza Molecular Delivery Corporation | Open-celled substrates for drug delivery |
US6701922B2 (en) * | 2001-12-20 | 2004-03-09 | Chrysalis Technologies Incorporated | Mouthpiece entrainment airflow control for aerosol generators |
US6772756B2 (en) | 2002-02-09 | 2004-08-10 | Advanced Inhalation Revolutions Inc. | Method and system for vaporization of a substance |
EP1503744A1 (en) * | 2002-05-13 | 2005-02-09 | Alexza Molecular Delivery Corporation | Delivery of drug amines through an inhalation route |
US20060193788A1 (en) * | 2002-11-26 | 2006-08-31 | Hale Ron L | Acute treatment of headache with phenothiazine antipsychotics |
US7074806B2 (en) * | 2002-06-06 | 2006-07-11 | Boehringer Ingelheim Pharmaceuticals, Inc. | Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
US7485143B2 (en) * | 2002-11-15 | 2009-02-03 | Abbott Cardiovascular Systems Inc. | Apparatuses and methods for heart valve repair |
KR100459905B1 (ko) * | 2002-11-21 | 2004-12-03 | 삼성전자주식회사 | 두 개의 잉크챔버 사이에 배치된 히터를 가진 일체형잉크젯 프린트헤드 및 그 제조방법 |
CN101371843B (zh) * | 2002-11-26 | 2012-09-26 | 艾利斯达医药品公司 | 洛沙平和阿莫沙平在制备治疗疼痛的药物中的应用 |
MXPA05005609A (es) * | 2002-11-26 | 2005-07-26 | Alexza Pharmaceuticals Inc | Tratamiento de dolor de cabeza con antipsicoticos suministrados por inhalacion. |
US7550133B2 (en) * | 2002-11-26 | 2009-06-23 | Alexza Pharmaceuticals, Inc. | Respiratory drug condensation aerosols and methods of making and using them |
US20040105818A1 (en) * | 2002-11-26 | 2004-06-03 | Alexza Molecular Delivery Corporation | Diuretic aerosols and methods of making and using them |
US7913688B2 (en) * | 2002-11-27 | 2011-03-29 | Alexza Pharmaceuticals, Inc. | Inhalation device for producing a drug aerosol |
ATE510174T1 (de) * | 2003-05-21 | 2011-06-15 | Alexza Pharmaceuticals Inc | Schlag gezündete unabhängige heizeinheit |
EP1656171B9 (en) * | 2003-08-04 | 2010-10-20 | Alexza Pharmaceuticals, Inc. | Substrates for drug delivery device and methods of preparing |
US20050037506A1 (en) * | 2003-08-04 | 2005-02-17 | Alexza Molecular Delivery Corporation | Methods of determining film thicknesses for an aerosol delivery article |
CA2551127A1 (en) * | 2003-12-15 | 2005-07-07 | Alexza Pharmaceuticals, Inc. | Treatment of breakthrough pain by drug aerosol inhalation |
WO2005059804A2 (en) * | 2003-12-16 | 2005-06-30 | Alexza Pharmaceuticals, Inc. | Methods for monitoring severity of panic attacks and other rapidly evolving medical events in real-time |
US7402777B2 (en) * | 2004-05-20 | 2008-07-22 | Alexza Pharmaceuticals, Inc. | Stable initiator compositions and igniters |
US7540286B2 (en) * | 2004-06-03 | 2009-06-02 | Alexza Pharmaceuticals, Inc. | Multiple dose condensation aerosol devices and methods of forming condensation aerosols |
EP2246086A3 (en) * | 2004-08-12 | 2012-11-21 | Alexza Pharmaceuticals, Inc. | Aerosol drug delivery device incorporating percussively activated heating unit |
US20060032496A1 (en) * | 2004-08-12 | 2006-02-16 | Alexza Molecular Delivery Corporation | Inhalation actuated percussive ignition system |
WO2006044421A2 (en) * | 2004-10-12 | 2006-04-27 | Alexza Pharmaceuticals, Inc. | Cardiac safe, rapid medication delivery |
MX2008012064A (es) * | 2006-03-23 | 2008-12-17 | Amgen Inc | Compuestos de amida 1-fenilsulfonil-diaza-heterociclica y sus usos como moduladores de hidroxiesteroide deshidrogenadas. |
US20080299048A1 (en) | 2006-12-22 | 2008-12-04 | Alexza Pharmaceuticals, Inc. | Mixed drug aerosol compositions |
ES2594867T3 (es) | 2007-03-09 | 2016-12-23 | Alexza Pharmaceuticals, Inc. | Unidad de calentamiento para usar en un dispositivo de administración de fármaco |
US20080306285A1 (en) | 2007-04-27 | 2008-12-11 | Alexza Pharmaceuticals, Inc. | Heat-Labile Prodrugs |
-
2002
- 2002-05-13 EP EP02741994A patent/EP1392262A1/en not_active Withdrawn
- 2002-05-13 US US10/146,516 patent/US6737042B2/en not_active Expired - Fee Related
- 2002-05-13 CA CA002446904A patent/CA2446904A1/en not_active Abandoned
- 2002-05-13 JP JP2003530268A patent/JP2005503425A/ja active Pending
- 2002-05-15 US US10/150,268 patent/US6780399B2/en not_active Expired - Fee Related
- 2002-05-15 US US10/150,267 patent/US6797259B2/en not_active Expired - Fee Related
- 2002-05-15 AU AU2002314784A patent/AU2002314784A1/en not_active Abandoned
- 2002-05-16 US US10/151,596 patent/US6855310B2/en not_active Expired - Fee Related
- 2002-05-16 US US10/151,626 patent/US6783753B2/en not_active Expired - Lifetime
- 2002-05-16 EP EP02729255A patent/EP1389095A1/en not_active Withdrawn
- 2002-05-17 EP EP02771848A patent/EP1392264B1/en not_active Expired - Lifetime
- 2002-05-17 JP JP2002590949A patent/JP4578772B2/ja not_active Expired - Fee Related
- 2002-05-17 AT AT02771848T patent/ATE401064T1/de not_active IP Right Cessation
- 2002-05-17 US US10/150,857 patent/US6716415B2/en not_active Expired - Lifetime
- 2002-05-17 ES ES02729235T patent/ES2312571T3/es not_active Expired - Lifetime
- 2002-05-17 ES ES08014271T patent/ES2341594T3/es not_active Expired - Lifetime
- 2002-05-17 CA CA002446990A patent/CA2446990C/en not_active Expired - Fee Related
- 2002-05-17 EP EP02729235A patent/EP1389094B1/en not_active Expired - Lifetime
- 2002-05-17 NZ NZ529422A patent/NZ529422A/en unknown
- 2002-05-17 AT AT02729235T patent/ATE406878T1/de active
- 2002-05-17 EP EP08014271A patent/EP1987823B1/en not_active Expired - Lifetime
- 2002-05-17 DE DE60235851T patent/DE60235851D1/de not_active Expired - Lifetime
- 2002-05-17 US US10/150,591 patent/US6780400B2/en not_active Expired - Lifetime
- 2002-05-17 AT AT08014271T patent/ATE462420T1/de not_active IP Right Cessation
- 2002-05-20 EP EP02731896A patent/EP1389097B1/en not_active Expired - Lifetime
- 2002-05-20 ES ES08014272T patent/ES2341392T3/es not_active Expired - Lifetime
- 2002-05-20 DE DE60228232T patent/DE60228232D1/de not_active Expired - Lifetime
- 2002-05-20 WO PCT/US2002/016118 patent/WO2002094236A1/en active Application Filing
- 2002-05-20 CA CA002446917A patent/CA2446917C/en not_active Expired - Lifetime
- 2002-05-20 JP JP2002590955A patent/JP4578773B2/ja not_active Expired - Lifetime
- 2002-05-20 AT AT08014272T patent/ATE462421T1/de not_active IP Right Cessation
- 2002-05-20 EP EP02737053A patent/EP1389098B1/en not_active Expired - Lifetime
- 2002-05-20 AT AT02737053T patent/ATE404173T1/de active
- 2002-05-20 MX MXPA03010703A patent/MXPA03010703A/es active IP Right Grant
- 2002-05-20 US US10/152,640 patent/US6743415B2/en not_active Expired - Fee Related
- 2002-05-20 ES ES02737053T patent/ES2311607T3/es not_active Expired - Lifetime
- 2002-05-20 AT AT02731896T patent/ATE404184T1/de not_active IP Right Cessation
- 2002-05-20 US US10/153,139 patent/US6814954B2/en not_active Expired - Lifetime
- 2002-05-20 EP EP08014272A patent/EP1990046B1/en not_active Expired - Lifetime
- 2002-05-20 US US10/152,652 patent/US6740307B2/en not_active Expired - Fee Related
- 2002-05-20 PT PT02737053T patent/PT1389098E/pt unknown
- 2002-05-20 DK DK02737053T patent/DK1389098T3/da active
- 2002-05-20 PL PL02363996A patent/PL363996A1/xx unknown
- 2002-05-20 AU AU2002310015A patent/AU2002310015B2/en not_active Expired
- 2002-05-20 US US10/152,639 patent/US6716416B2/en not_active Expired - Lifetime
- 2002-05-20 NZ NZ529419A patent/NZ529419A/en unknown
- 2002-05-20 DE DE60235852T patent/DE60235852D1/de not_active Expired - Lifetime
- 2002-05-20 EP EP02737054A patent/EP1389099A1/en not_active Withdrawn
- 2002-05-21 JP JP2002590964A patent/JP2004535403A/ja active Pending
- 2002-05-21 AU AU2002303833A patent/AU2002303833B2/en not_active Ceased
- 2002-05-21 CA CA002446916A patent/CA2446916C/en not_active Expired - Fee Related
- 2002-05-21 ES ES02731894T patent/ES2324023T3/es not_active Expired - Lifetime
- 2002-05-21 PT PT02731894T patent/PT1389096E/pt unknown
- 2002-05-21 NZ NZ529420A patent/NZ529420A/en unknown
- 2002-05-21 US US10/153,839 patent/US6776978B2/en not_active Expired - Lifetime
- 2002-05-21 US US10/153,831 patent/US6740308B2/en not_active Expired - Lifetime
- 2002-05-21 US US10/153,311 patent/US6884408B2/en not_active Expired - Fee Related
- 2002-05-21 AT AT02731894T patent/ATE425746T1/de active
- 2002-05-21 EP EP02731930A patent/EP1392257B1/en not_active Expired - Lifetime
- 2002-05-21 NZ NZ529421A patent/NZ529421A/en unknown
- 2002-05-21 CA CA002447521A patent/CA2447521C/en not_active Expired - Fee Related
- 2002-05-21 AT AT02731930T patent/ATE401063T1/de not_active IP Right Cessation
- 2002-05-21 EP EP02731894A patent/EP1389096B9/en not_active Expired - Lifetime
- 2002-05-22 DE DE60220909T patent/DE60220909T2/de not_active Expired - Lifetime
- 2002-05-22 PL PL02363997A patent/PL363997A1/xx not_active Application Discontinuation
- 2002-05-22 US US10/155,705 patent/US6805854B2/en not_active Expired - Fee Related
- 2002-05-22 JP JP2002590938A patent/JP2004531556A/ja active Pending
- 2002-05-22 NZ NZ529418A patent/NZ529418A/en unknown
- 2002-05-22 US US10/155,703 patent/US6803031B2/en not_active Expired - Fee Related
- 2002-05-22 AT AT02737132T patent/ATE365548T1/de not_active IP Right Cessation
- 2002-05-22 CA CA002447166A patent/CA2447166C/en not_active Expired - Fee Related
- 2002-05-22 EP EP02737132A patent/EP1392259B1/en not_active Expired - Lifetime
- 2002-05-23 AT AT02737120T patent/ATE418330T1/de not_active IP Right Cessation
- 2002-05-23 AT AT02739410T patent/ATE418971T1/de not_active IP Right Cessation
- 2002-05-23 EP EP02737120A patent/EP1390021B1/en not_active Expired - Lifetime
- 2002-05-23 US US10/155,097 patent/US6716417B2/en not_active Expired - Fee Related
- 2002-05-23 EP EP02739410A patent/EP1392261B1/en not_active Expired - Lifetime
- 2002-05-23 CA CA2447099A patent/CA2447099C/en not_active Expired - Fee Related
- 2002-05-23 MX MXPA03010702A patent/MXPA03010702A/es active IP Right Grant
- 2002-05-23 US US10/154,765 patent/US6814955B2/en not_active Expired - Fee Related
- 2002-05-23 JP JP2002590960A patent/JP2004532860A/ja active Pending
- 2002-05-23 US US10/154,594 patent/US6740309B2/en not_active Expired - Fee Related
- 2002-05-23 NZ NZ529416A patent/NZ529416A/en unknown
- 2002-05-23 PL PL02364002A patent/PL364002A1/xx unknown
-
2003
- 2003-12-12 US US10/735,199 patent/US7070761B2/en not_active Expired - Fee Related
- 2003-12-12 US US10/735,497 patent/US7070762B2/en not_active Expired - Fee Related
- 2003-12-12 US US10/734,902 patent/US7029658B2/en not_active Expired - Fee Related
- 2003-12-12 US US10/735,496 patent/US7005121B2/en not_active Expired - Fee Related
- 2003-12-12 US US10/735,198 patent/US7008615B2/en not_active Expired - Fee Related
- 2003-12-30 US US10/749,539 patent/US7078018B2/en not_active Expired - Lifetime
- 2003-12-30 US US10/749,537 patent/US7078017B2/en not_active Expired - Lifetime
- 2003-12-30 US US10/749,536 patent/US7094392B2/en not_active Expired - Fee Related
- 2003-12-30 US US10/749,783 patent/US7078019B2/en not_active Expired - Fee Related
- 2003-12-30 US US10/749,535 patent/US7115250B2/en not_active Expired - Fee Related
- 2003-12-30 US US10/750,303 patent/US7078020B2/en not_active Expired - Lifetime
-
2004
- 2004-01-27 US US10/766,149 patent/US7087216B2/en not_active Expired - Lifetime
- 2004-01-27 US US10/766,566 patent/US7060254B2/en not_active Expired - Fee Related
- 2004-01-27 US US10/766,574 patent/US7045118B2/en not_active Expired - Lifetime
- 2004-01-27 US US10/766,279 patent/US7087217B2/en not_active Expired - Fee Related
- 2004-01-27 US US10/766,634 patent/US7070763B2/en not_active Expired - Lifetime
- 2004-01-27 US US10/766,647 patent/US7070764B2/en not_active Expired - Fee Related
- 2004-01-28 US US10/767,115 patent/US7052679B2/en not_active Expired - Lifetime
- 2004-01-29 US US10/769,197 patent/US7063831B2/en not_active Expired - Fee Related
- 2004-01-29 US US10/768,205 patent/US7070765B2/en not_active Expired - Lifetime
- 2004-01-29 US US10/768,281 patent/US7169378B2/en not_active Expired - Lifetime
- 2004-01-29 US US10/768,293 patent/US7067114B2/en not_active Expired - Fee Related
- 2004-01-29 US US10/768,220 patent/US7063830B2/en not_active Expired - Fee Related
- 2004-01-30 US US10/769,051 patent/US7033575B2/en not_active Expired - Fee Related
- 2004-01-30 US US10/769,046 patent/US7070766B2/en not_active Expired - Fee Related
- 2004-02-09 US US10/775,586 patent/US7048909B2/en not_active Expired - Fee Related
- 2004-02-09 US US10/775,583 patent/US7018620B2/en not_active Expired - Fee Related
- 2004-03-03 US US10/791,915 patent/US7005122B2/en not_active Expired - Fee Related
- 2004-03-03 US US10/792,239 patent/US7014840B2/en not_active Expired - Fee Related
- 2004-03-31 US US10/814,690 patent/US7014841B2/en not_active Expired - Lifetime
- 2004-03-31 US US10/813,722 patent/US7063832B2/en not_active Expired - Fee Related
- 2004-03-31 US US10/813,721 patent/US7022312B2/en not_active Expired - Lifetime
- 2004-03-31 US US10/814,998 patent/US7108847B2/en not_active Expired - Fee Related
- 2004-04-01 US US10/816,567 patent/US7052680B2/en not_active Expired - Fee Related
- 2004-04-01 US US10/816,407 patent/US7011820B2/en not_active Expired - Fee Related
- 2004-04-01 US US10/816,492 patent/US7008616B2/en not_active Expired - Fee Related
- 2004-04-01 US US10/815,527 patent/US6994843B2/en not_active Expired - Fee Related
-
2006
- 2006-03-07 US US11/370,628 patent/US7442368B2/en not_active Expired - Fee Related
- 2006-04-04 US US11/398,383 patent/US7449172B2/en not_active Expired - Lifetime
- 2006-05-24 US US11/439,475 patent/US7465435B2/en not_active Expired - Fee Related
- 2006-05-30 US US11/442,917 patent/US7465436B2/en not_active Expired - Fee Related
- 2006-06-13 US US11/451,853 patent/US7485285B2/en not_active Expired - Fee Related
- 2006-06-16 US US11/454,573 patent/US7465437B2/en not_active Expired - Fee Related
- 2006-06-30 US US11/479,361 patent/US7524484B2/en not_active Expired - Fee Related
- 2006-06-30 US US11/479,509 patent/US7507398B2/en not_active Expired - Fee Related
- 2006-06-30 US US11/479,892 patent/US7449174B2/en not_active Expired - Fee Related
- 2006-07-05 US US11/481,279 patent/US7449175B2/en not_active Expired - Fee Related
- 2006-07-18 US US11/488,943 patent/US20060257329A1/en not_active Abandoned
- 2006-07-18 US US11/488,932 patent/US7601337B2/en not_active Expired - Lifetime
- 2006-08-07 US US11/501,246 patent/US7510702B2/en not_active Expired - Fee Related
- 2006-08-07 US US11/500,735 patent/US7445768B2/en not_active Expired - Fee Related
- 2006-08-22 US US11/507,986 patent/US7491047B2/en not_active Expired - Fee Related
- 2006-09-19 US US11/523,685 patent/US7507397B2/en not_active Expired - Fee Related
-
2007
- 2007-01-09 US US11/621,397 patent/US7468179B2/en not_active Expired - Fee Related
-
2008
- 2008-03-27 US US12/057,330 patent/US7988952B2/en not_active Expired - Fee Related
-
2009
- 2009-03-27 US US12/413,339 patent/US8173107B2/en not_active Expired - Fee Related
-
2010
- 2010-07-23 JP JP2010165688A patent/JP5629151B2/ja not_active Expired - Lifetime
-
2013
- 2013-08-19 FR FR13C0051C patent/FR13C0051I1/fr active Active
- 2013-08-19 BE BE2013C054C patent/BE2013C054I2/nl unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BE2013C054I2 (es) | ||
WO2002094244A3 (en) | Delivery of benzodiazepines through an inhalation route | |
WO2002094218A3 (en) | Delivery of alprazolam, estazolam, midazolam or triazolam through an inhalation route | |
HUS1900056I1 (hu) | Légzési rendellenességek kezelésére alkalmas, glikopirrolát tartalmú száraz porkészítményt tartalmazó inhaláló készülék és alkalmazása | |
AU5900701A (en) | Novel composition | |
NZ507151A (en) | Pulmonary and nasal delivery of raloxifene | |
IL153281A0 (en) | Highly efficient delivery of a large therapeutic mass aerosol | |
AU2002366203A1 (en) | Medicament dispensing system | |
TW200607538A (en) | Medicament inhaler device | |
WO2000066107A3 (en) | Antimalarian agents for the treatment of asthma | |
WO2002094219A3 (en) | Delivery of erectile dysfunction drugs through an inhalation route | |
WO2002094216A3 (en) | Delivery of stimulants through an inhalation route | |
MXPA04007294A (es) | Composicion para inhalacion. | |
WO2003094694A3 (en) | Hand held device for inhalation therapy and method of use thereof |